<SEC-DOCUMENT>0001610618-17-000052.txt : 20171020
<SEC-HEADER>0001610618-17-000052.hdr.sgml : 20171020
<ACCEPTANCE-DATETIME>20171019183040
ACCESSION NUMBER:		0001610618-17-000052
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20171019
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171020
DATE AS OF CHANGE:		20171019

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cidara Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001610618
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				461537286
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36912
		FILM NUMBER:		171145548

	BUSINESS ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-752-6170

	MAIL ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	K2 THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20140611
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cdtx8-k2017x10x19.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sF7A3D18F2F05B6D295D132EAB6C3DA23"></a></div><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:5px;text-align:center;-sec-extract:summary;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES </font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION </font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">WASHINGTON, D.C. 20549 </font></div><div style="line-height:100%;padding-bottom:2px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;"><hr></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 8-K </font></div><div style="line-height:100%;padding-bottom:2px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;"><hr></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CURRENT REPORT </font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">PURSUANT TO SECTION 13 OR 15(d) </font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">OF THE SECURITIES EXCHANGE ACT OF 1934 </font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Date of Report (Date of earliest event reported): October 19, 2017</font></div><div style="line-height:100%;padding-bottom:2px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;"><hr></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:24pt;"><font style="font-family:inherit;font-size:24pt;font-weight:bold;">Cidara Therapeutics, Inc. </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Exact name of registrant as specified in its charter) </font></div><div style="line-height:100%;padding-bottom:2px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;"><hr></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">001-36912 </font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Commission File Number)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:51%;"></td><td style="width:1%;"></td><td style="width:48%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Delaware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">46-1537286</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(State or other jurisdiction</font></div><div style="padding-bottom:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">of incorporation)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(IRS Employer</font></div><div style="padding-bottom:1px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Identification No.)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">6310 Nancy Ridge Drive, Suite 101</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">San Diego, California 92121 </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(858) 752-6170</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrants Principal Executive Offices)</font></div><div style="line-height:120%;"><hr></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:4%;"></td><td style="width:96%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).&#160; </font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">Emerging growth company </font><font style="font-family:Wingdings;font-size:10pt;">x</font></div><div style="line-height:144%;text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 1.01 Entry into a Material Definitive Agreement. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The disclosure set forth below under Item 3.02 is incorporated herein by reference. </font></div><div style="line-height:120%;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 3.02 Unregistered Sales of Equity Securities. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 19, 2017, Cidara Therapeutics, Inc. (the &#8220;Company&#8221;) entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with certain institutional investors named therein (the &#8220;Purchasers&#8221;), pursuant to which the Company agreed to sell and issue to the Purchasers an aggregate of 3,360,000 shares of its Common Stock (the &#8220;Shares&#8221;) at a purchase price of $6.00 per share (the &#8220;Offering&#8221;). The aggregate purchase price to be paid by the Purchasers for the Shares is approximately $20,000,000, and the Company expects to receive net proceeds of approximately $19,000,000, after deducting commissions and estimated offering expenses. The closing of the Offering (the &#8220;Closing&#8221;) is expected to occur on October 24, 2017. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Purchase Agreement also requires the Company to register the Shares for resale. The Company is required to prepare and file a registration statement with the Securities and Exchange Commission within 45 days of the Closing and to use commercially reasonable efforts to have such registration statement declared effective as soon as practicable but no later than within 90 days after the Closing, if there is no review by the Securities and Exchange Commission, and within 120 days of the Closing in the event of such review. As set forth in the Purchase Agreement, if the Company fails to comply with certain obligations with respect to filing and securing effectiveness of such registration statement, the Company would be obligated to pay liquidated damages to the Purchasers in the amount of 1% on the day of such default and on every 30</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;day thereafter, up to a maximum of 6% of each Purchaser&#8217;s aggregate investment.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Shares were offered and sold without registration under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or state securities laws. The Company has relied on the exemption from the registration requirements of the Securities Act provided by Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D thereunder. In connection with the Purchasers&#8217; execution of the Purchase Agreement, each Purchaser represented to the Company that it is an &#8220;accredited investor&#8221; as defined in Regulation D of the Securities Act and that the securities purchased by each Purchaser were acquired solely for its own account and for investment purposes, and not with a view to the future sale or distribution. Neither this Current Report on Form 8-K, nor the exhibits attached hereto is an offer to sell or the solicitation of an offer to buy the Shares. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Purchase Agreement contains customary representations, warranties and covenants that were made solely for the benefit of the parties to the Purchase Agreement. Such representations, warranties and covenants (i) are intended as a way of allocating risk between the parties to the Purchase Agreement and not as statements of fact, and (ii) may apply standards of materiality in a way that is different from what may be viewed as material by stockholders of, or other investors in, the Company. Accordingly, the Purchase Agreement is included with this filing only to provide investors with information regarding the terms of transaction and not to provide investors with any other factual information regarding the Company. Investors should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company or any of its subsidiaries or affiliates. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Purchase Agreement, which subsequent information may or may not be fully reflected in public disclosures. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The above description of the material terms of the Offering is qualified in its entirety by reference to the Purchase Agreement, which is attached hereto as Exhibit 10.1 and incorporated herein by reference. </font></div><div style="line-height:120%;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 7.01 Other Events. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 19, 2017, the Company issued the press release attached hereto as Exhibit 99.1 regarding the Offering described in Item 3.02. A copy of the press release is attached hereto as Exhibit 99.1. </font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 9.01. Financial Statements and Exhibits. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d) Exhibits </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.4126984126984%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:7%;"></td><td style="width:4%;"></td><td style="width:89%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex101-securitiespurchaseag.htm"><font style="font-family:inherit;font-size:10pt;">Securities Purchase Agreement, dated October 19, 2017, between the Company and the purchasers listed therein.</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:1px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex991-pressrelease2017x10x.htm"><font style="font-family:inherit;font-size:10pt;">Press Release, dated October 19, 2017.</font></a></div></td></tr></table></div></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: October 20, 2017 </font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:42.26190476190476%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:10%;"></td><td style="width:3%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cidara Therapeutics, Inc.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Jeffrey L. Stein</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jeffrey L. Stein</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President and Chief Financial Officer</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Principal Executive Officer)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101-securitiespurchaseag.htm
<DESCRIPTION>SECURITIES PURCHASE AGREEMENT
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sAAC4B6219458C2CFC32B35F9990B9BD9"></a></div><div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Exhibit 10.1</font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">SECURITIES PURCHASE AGREEMENT </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">This SECURITIES PURCHASE AGREEMENT (this &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Agreement</font><font style="font-family:inherit;font-size:11pt;">&#8221;) is made and entered into as of October&#160;19, 2017 (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Effective Date</font><font style="font-family:inherit;font-size:11pt;">&#8221;) by and among Cidara Therapeutics, Inc., a Delaware corporation (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Company</font><font style="font-family:inherit;font-size:11pt;">&#8221;), and each of those persons and entities, severally and not jointly, listed as a Purchaser on the Schedule of Purchasers attached as </font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Schedule I</font><font style="font-family:inherit;font-size:11pt;">&#32;hereto (each a &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Purchaser</font><font style="font-family:inherit;font-size:11pt;">&#8221; and together the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Purchasers</font><font style="font-family:inherit;font-size:11pt;">&#8221;). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">RECITALS </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">WHEREAS, the Company and the Purchasers are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Securities Act</font><font style="font-family:inherit;font-size:11pt;">&#8221;), and Rule 506 of Regulation D as promulgated by the United States Securities and Exchange Commission (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Commission</font><font style="font-family:inherit;font-size:11pt;">&#8221;) under the Securities Act; and</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">WHEREAS, the Company desires to sell to the Purchasers, and the Purchasers desire to purchase from the Company, shares of Common Stock, $0.0001 par value per share (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Common Stock</font><font style="font-family:inherit;font-size:11pt;">&#8221;), in accordance with the terms and provisions of this Agreement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">NOW, THEREFORE, in consideration of the foregoing and the mutual representations, warranties and covenants herein contained, the parties hereto hereby agree as follows: </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Section 1.</font><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Authorization of Shares</font><font style="font-family:inherit;font-size:11pt;">. The Company has authorized the sale and issuance of an aggregate of 3,360,000 shares of Common Stock on the terms and subject to the conditions set forth in this Agreement. The shares of Common Stock sold hereunder at the Closing (as defined below) shall be referred to as the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Shares</font><font style="font-family:inherit;font-size:11pt;">.&#8221; </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Section 2.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Sale and Purchase of the Shares</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.01</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Upon the terms and subject to the conditions herein contained, the Company agrees to sell to each Purchaser, and each Purchaser agrees to purchase from the Company at the Closing (as defined in Section 3), that number of Shares set forth opposite such Purchaser&#8217;s name on </font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Schedule I</font><font style="font-family:inherit;font-size:11pt;">&#32;hereto (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Schedule of Purchasers</font><font style="font-family:inherit;font-size:11pt;">&#8221;) for the purchase price set forth opposite such Purchaser&#8217;s name, which amount represents the number of Shares to be purchased by such Purchaser multiplied by the price per Share of $6.00. The purchase price to be paid by each Purchaser, as set forth on </font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Schedule I</font><font style="font-family:inherit;font-size:11pt;">, shall be referred to as the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Aggregate Purchase Price</font><font style="font-family:inherit;font-size:11pt;">.&#8221; Each Purchaser shall severally, and not jointly, be liable for only the purchase of the Shares that appear on the Schedule of Purchasers opposite such Purchaser&#8217;s name. The Company&#8217;s agreement with each of the Purchasers is a separate agreement and the sale of Shares to each of the Purchasers is a separate sale. The obligations of each Purchaser hereunder are expressly not conditioned on the purchase by any or all of the other Purchasers of the Shares such other Purchasers have agreed to purchase. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.02</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">At or prior to the Closing, each Purchaser will pay the purchase price set forth opposite such Purchaser&#8217;s name on </font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Schedule I</font><font style="font-family:inherit;font-size:11pt;">&#32;by wire transfer of immediately available funds in accordance with wire instructions provided by the Company to the Purchasers prior to the Closing. On or before the Closing, the Company will instruct its transfer agent to either deliver stock certificates to the Purchasers or make book-entry notations representing the Shares, in each case against delivery of the Aggregate Purchase Price. The foregoing notwithstanding, if the Purchaser has indicated to the Company at the time of execution of this Agreement a need to settle on a &#8220;delivery versus payment&#8221; basis, then the Company shall either deliver to such Purchaser (or such Purchaser&#8217;s designated custodian) the original stock certificates or make a book-entry notation reflecting ownership of the Shares whereupon following receipt of such certificate(s) or written confirmation from the Company&#8217;s transfer agent that a book-entry notation has been made, then the Purchaser shall then promptly wire the Aggregate Purchase Price as provided in this Section 2. </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Section 3.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Closing</font><font style="font-family:inherit;font-size:11pt;">. Subject to the satisfaction of the closing conditions set forth in Section 7, the closing with respect to the transactions contemplated in Section 2 hereof (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Closing</font><font style="font-family:inherit;font-size:11pt;">&#8221;), shall take place at the offices of Cooley&#160;LLP, at 4401 Eastgate Mall, San Diego, California, on the third Business Day after the Effective Date (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Closing Date</font><font style="font-family:inherit;font-size:11pt;">&#8221;), or at such other time and place as the Company and Purchasers may agree, including remotely via the exchange of documents and signatures. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Section 4.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Representations and Warranties of the Purchasers</font><font style="font-family:inherit;font-size:11pt;">. Each Purchaser, severally but not jointly, represents and warrants to the Company that the statements contained in this Section 4 are true and correct as of the Effective Date, and will be true and correct as of the date of the Closing Date: </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.01</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Validity</font><font style="font-family:inherit;font-size:11pt;">. The execution, delivery and performance of this Agreement and the other instruments referred to herein, in each case to which the Purchaser is a party, and the consummation by the Purchaser of the transactions contemplated hereby, have been duly authorized by all necessary corporate, partnership, limited liability or similar actions, as applicable, on the part of such Purchaser. This Agreement has been duly executed and delivered by the Purchaser, and the other instruments referred to herein to which it is a party will be duly executed and delivered by the Purchaser, and each such agreement and other instruments constitutes or will constitute a valid and binding obligation of the Purchaser, enforceable against it in accordance with its terms, except as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and any other laws of general application affecting enforcement of creditors&#8217; rights generally, and as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.02</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Brokers</font><font style="font-family:inherit;font-size:11pt;">. There is no broker, investment banker, financial advisor, finder or other Person which has been retained by or is authorized to act on behalf of the Purchaser who might be entitled to any fee or commission for which the Company will be liable in connection with the execution of this Agreement and the consummation of the transactions contemplated hereby. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.03</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Investment Representations and Warranties</font><font style="font-family:inherit;font-size:11pt;">. The Purchaser understands and agrees that the offering and sale of the Shares has not been registered under the Securities Act or any applicable state securities laws and is being made in reliance upon federal and state exemptions for transactions not involving a public offering which depend upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser&#8217;s representations as expressed herein. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.04</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Investor Questionnaire</font><font style="font-family:inherit;font-size:11pt;">. In connection with the filing of a Registration Statement, the Company may require the Purchaser to furnish to the Company such information regarding the Purchaser and the Registrable Securities, as the Company may reasonably request in writing and as shall reasonably be required in connection with the filing of the Registration Statement. At least five Business Days prior to the first anticipated filing date of such Registration Statement, the Company shall notify the Purchaser of any information the Company reasonably requests from the Purchaser, to the extent related to the Registration Statement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.05</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Acquisition for Own Account; No Control Intent</font><font style="font-family:inherit;font-size:11pt;">. The Purchaser is acquiring the Shares for its own account for investment and not with a view toward distribution in a manner which would violate the Securities Act or any applicable state securities laws. Purchaser is not party to any agreement providing for or contemplating the distribution of any of the Shares. The Purchaser has no present intent to effect a &#8220;change of control&#8221; of the Company as such term is understood under the rules promulgated pursuant to Section 13(d) of the Exchange Act. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.06</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Ability to Protect Its Own Interests and Bear Economic Risks</font><font style="font-family:inherit;font-size:11pt;">. The Purchaser, by reason of the business and financial experience of its management, has the capacity to protect its own interests in connection with the transactions contemplated by this Agreement and is capable of evaluating the merits and risks of the investment in the Shares. The Purchaser is able to bear the economic risk of an investment in the Shares and is able to sustain a loss of all of its investment in the Shares without economic hardship, if such a loss should occur. </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">2.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.07</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Accredited Investor; No Bad Actor</font><font style="font-family:inherit;font-size:11pt;">. The Purchaser is an &#8220;accredited investor&#8221; as that term is defined in Rule 501(a) under the Securities Act. Such Purchaser has not taken any of the actions set forth in, and is not subject to, the disqualification provisions of Rule 506(d)(1) of the Securities Act. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.08</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Access to Information</font><font style="font-family:inherit;font-size:11pt;">. The Purchaser has been given access to Company documents, records, and other information, and has had adequate opportunity to ask questions of, and receive answers from, the Company&#8217;s officers, employees, agents, accountants, and representatives concerning the Company&#8217;s business, operations, financial condition, assets, liabilities, and all other matters relevant to its investment in the Shares. Purchaser understands that an investment in the Shares bears significant risk and represents that it has reviewed the SEC Reports, which serve to qualify certain of the Company representations set forth below. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.09</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Non-Reliance on Placement Agent</font><font style="font-family:inherit;font-size:11pt;">. The Purchaser has, in connection with its decision to purchase the Shares set forth on Schedule I attached hereto, relied solely upon the representations and warranties of the Company contained herein, and such Purchaser has not relied on any placement agent in negotiating the terms of its investment in the Shares. In making a decision to purchase the Shares, such Purchaser has not received or relied on any communication, investment advice or recommendation from any placement agent. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.10</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Restricted Shares</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Purchaser understands that the Shares will be characterized as &#8220;restricted securities&#8221; under the federal securities laws inasmuch as they are being acquired from the Company in a private placement under Section 4(a)(2) of the Securities Act and that under such laws and applicable regulations such Shares may be resold without registration under the Securities Act only in certain limited circumstances. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Purchaser acknowledges that the Shares must be held indefinitely unless subsequently registered under the Securities Act and under applicable state securities laws or an exemption from such registration is available. The Purchaser understands that the Company is under no obligation to register the Shares, except as provided in this Agreement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Purchaser is aware of the provisions of Rule 144 under the Securities Act, which permit limited resale of securities purchased in a private placement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.11</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Tax Advisors</font><font style="font-family:inherit;font-size:11pt;">. The Purchaser has had the opportunity to review with the Purchaser&#8217;s own tax advisors the federal, state and local tax consequences of this investment, where applicable, and the transactions contemplated by this Agreement. The Purchaser is relying solely on the Purchaser&#8217;s own determination as to tax consequences or the advice of such tax advisors and not on any statements or representations of the Company or any of its agents and understands that the Purchaser (and not the Company) shall be responsible for the Purchaser&#8217;s own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.12</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Short Sales</font><font style="font-family:inherit;font-size:11pt;">. Between the time the Purchaser learned about the offering contemplated by this Agreement and the public announcement of the offering, the Purchaser has not engaged in any short sales (as defined in Rule 200 of Regulation SHO under the Exchange Act (&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Short Sales</font><font style="font-family:inherit;font-size:11pt;">&#8221;)) or similar transactions with respect to the Common Stock, nor has the Purchaser, directly or indirectly, caused any Person to engage in any Short Sales or similar transactions with respect to the Common Stock. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#8217;s assets, the representation set forth above shall apply only with respect to the portion of assets managed by the portfolio managers that have knowledge about the financing transaction contemplated by this Agreement. </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.13</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">No Interested Stockholder</font><font style="font-family:inherit;font-size:11pt;">. After giving effect to the purchase of the Shares at the Closing, the Purchaser will not be deemed to be an &#8220;interested stockholder&#8221; within the meaning of Section 203 of the Delaware General Corporation Law. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Section 5.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Representations and Warranties by the Company</font><font style="font-family:inherit;font-size:11pt;">. Assuming the accuracy of the representations and warranties of the Purchasers set forth in Section 4 and except as set forth in the SEC Reports (defined below), which disclosures serve to qualify these representations and warranties in their entirety, the Company represents and warrants to the Purchasers that the statements contained in this Section 5 are true and correct as of the Effective Date, and will be true and correct as of the date of the Closing Date: </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.01</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Organization and Good Standing</font><font style="font-family:inherit;font-size:11pt;">. The Company and each Subsidiary: (a) is duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its formation, (b) is duly qualified to do business as a foreign entity and is in good standing in each jurisdiction where the nature of the property owned or leased by it or the nature of the business conducted by it makes such qualification necessary, except where the failure to be so qualified would not have a Material Adverse Effect, and (c) has all requisite corporate power and authority to own or lease and operate its assets and carry on its business as presently being conducted as disclosed in the SEC Reports. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.02</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Corporate Power and Authority; Valid Issuance of Shares</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Company has all requisite corporate power and has taken all necessary corporate action required for the due authorization, execution, delivery and performance by the Company of this Agreement and the other Transaction Documents and the consummation of the transactions contemplated hereby and thereby. The execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the transactions contemplated hereby, have been duly authorized by the Company&#8217;s board of directors or a duly authorized committee thereof and no further consent or authorization of the Company, its board of directors or its stockholders is required. This Agreement has been duly executed and delivered by the Company, and the other instruments referred to herein to which it is a party will be duly executed and delivered by the Company, and each such agreement constitutes or will constitute a legal, valid and binding obligation of the Company enforceable against it in accordance with its terms, except to the extent that enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and any other laws of general application affecting enforcement of creditors&#8217; rights generally, and as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Shares have been duly and validly authorized and, when issued and paid for pursuant to this Agreement, the Shares will be validly issued, fully paid and non-assessable, and shall be free and clear of all encumbrances (other than restrictions on transfer under the Transaction Documents arising under applicable federal and state securities laws), and will not be subject to preemptive rights or other similar rights of stockholders of the Company </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.03</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Consents</font><font style="font-family:inherit;font-size:11pt;">. Neither the execution, delivery or performance of this Agreement by the Company, nor the consummation by it of the obligations and transactions contemplated hereby (including, without limitation, the issuance, the reservation for issuance and the delivery of the Shares and the provision to the Purchaser of the rights contemplated by the Transaction Documents) requires any consent of, authorization by, exemption from, filing with or notice to any Governmental Entity or any other Person, other than filings required under applicable U.S. federal and state securities laws. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.04</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">No Conflicts</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby (including, without limitation, the issuance, the reservation for issuance and the delivery of the Shares and the provision to the Purchaser of the rights contemplated by the Transaction Documents) </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">will not (a) result in a violation of the Company&#8217;s Certificate of Incorporation, the Company&#8217;s Bylaws or any equivalent organizational document of the Company or any Subsidiary (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Charter Documents</font><font style="font-family:inherit;font-size:11pt;">&#8221;) or require the approval of the Company&#8217;s stockholders, (b) violate, conflict with or result in the breach of the terms, conditions or provisions of or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give rise to any right of termination, acceleration or cancellation under, any material agreement, lease, mortgage, license, indenture, instrument or other contract to which the Company or any Subsidiary is a party, (c) result in a violation of any law, rule, regulation, order, judgment or decree (including, without limitation, U.S. federal and state securities laws and regulations and regulations of any self-regulatory organizations to which the Company or its securities are subject) applicable to the Company or any Subsidiary or by which any property or asset of the Company or any Subsidiary is bound or affected, (d) result in a violation of or require stockholder approval under any rule or regulation of The NASDAQ Stock Market (&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">NASDAQ</font><font style="font-family:inherit;font-size:11pt;">&#8221;), or (e) result in the creation of any encumbrance upon any of the Company&#8217;s or any of its Subsidiary&#8217;s assets. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Neither the Company nor any Subsidiary is (i) in violation of its Charter Documents, (ii) in default (and no event has occurred which, with notice or lapse of time or both, would cause the Company or any Subsidiary to be in default) under, nor has there occurred any event giving others (with notice or lapse of time or both) any rights of termination, amendment, acceleration or cancellation of, any material agreement, indenture or instrument to which the Company or any Subsidiary is a party, except where such default would not have a Material Adverse Effect, nor has the Company or any Subsidiary received written notice of a claim that it is in default under, or that it is in violation of, any Material Contract (whether or not such default or violation has been waived), except where such default would not have a Material Adverse Effect, (iii) in violation of, or in receipt of written notice that it is in violation of, any law, ordinance or regulation of any Governmental Entity, except where such violation would not result in a Material Adverse Effect, and (iv) in violation of any order of any Governmental Entity having jurisdictional over the Company or any Subsidiary or any of the Company&#8217;s or any Subsidiary&#8217;s properties or assets. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.05</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Capitalization</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">As of September 30, 2017, the authorized capital stock of the Company consists of 210,000,000 shares of capital stock, of which 200,000,000 are designated as Common Stock and 10,000,000 are designated as preferred stock, $0.0001 par value per share (&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Preferred Stock</font><font style="font-family:inherit;font-size:11pt;">&#8221;). As of September 30, 2017: (i) 16,879,006 shares of Common Stock were issued and outstanding; (ii) 3,093,599 shares of Common Stock were issuable (and such number was reserved for issuance) upon exercise of options to purchase Common Stock (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Options</font><font style="font-family:inherit;font-size:11pt;">&#8221;) outstanding as of such date; (iii) 230,000 shares of Common Stock were issuable (and such number was reserved for issuance) upon vesting of restricted stock units for the issuance of Common Stock (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">RSUs</font><font style="font-family:inherit;font-size:11pt;">&#8221;) outstanding as of such date; and (iv) 17,331 shares of Common Stock were issuable (and such number was reserved for issuance) upon exercise of warrants to purchase Common Stock (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Warrants</font><font style="font-family:inherit;font-size:11pt;">&#8221;) outstanding as of such date. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">As of September 30, 2017, except for: (i) the Options, (ii) the RSUs, and (iii) the Warrants, there were no options, warrants or other rights to acquire capital stock or other equity interests from the Company, or securities convertible into or exchangeable for such capital stock or other equity interests. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.06</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Material Contracts</font><font style="font-family:inherit;font-size:11pt;">. Each Material Contract is the legal, valid and binding obligation of the Company or a Subsidiary, as the case may be, enforceable against the Company or such Subsidiary, as the case may be, in accordance with its terms, except to the extent that enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and any other laws of general application affecting enforcement of creditors&#8217; rights generally, and as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies. The Company and each Subsidiary, as the case may be, is in compliance with all material terms of the Material Contracts to which it is a party, and there has not occurred any breach, violation or default or any event that, with the lapse of time, the giving of notice or the election of any Person, or any combination thereof, would constitute a breach, violation or default by the Company or any Subsidiary under any such Material Contract or, to the knowledge of the Company and each Subsidiary, by any other Person to any such contract except where such breach, violation or default would not have a Material Adverse Effect. Neither the Company nor any </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Subsidiary has been notified that any party to any Material Contract intends to cancel, terminate, not renew or exercise an option under any Material Contract, whether in connection with the transactions contemplated hereby or otherwise. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.07</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">NASDAQ</font><font style="font-family:inherit;font-size:11pt;">. The Common Stock is listed on The Nasdaq Global Market. To the Company&#8217;s knowledge, there are no proceedings to revoke or suspend such listing or the listing of the Shares. The Company is in compliance with the requirements of NASDAQ for continued listing of the Common Stock thereon and any other applicable NASDAQ listing and maintenance requirements, and the execution, delivery and performance of this Agreement by the Company and the consummation by the Company of the transactions contemplated hereby (including the issuance of the Shares) will not result in any noncompliance by the Company with any such requirements. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.08</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">No Integrated Offering</font><font style="font-family:inherit;font-size:11pt;">. Neither the Company, any Subsidiary, nor any of the Company&#8217;s or any Subsidiary&#8217;s Affiliates or any other Person acting on the Company&#8217;s or any Subsidiary&#8217;s behalf, has directly or indirectly engaged in any form of general solicitation or general advertising with respect to the Shares, nor have any of such Persons made any offers or sales of any security of the Company, any Subsidiary or any of the Company&#8217;s or any Subsidiary&#8217;s Affiliates or solicited any offers to buy any security of the Company, any Subsidiary or any of the Company&#8217;s or any Subsidiary&#8217;s Affiliates under circumstances that would require registration of the Shares under the Securities Act or any other securities laws or cause this offering of Shares to be integrated with any prior offering of securities of the Company or any Subsidiary for purposes of the Securities Act in any manner that would affect the validity of the private placement exemption under the Securities Act for the offer and sale of the Shares hereunder.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.09</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">SEC Reports; Financial Statements; Shell Company Status</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Company&#8217;s Common Stock is registered under Section 12 of the Exchange Act. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, since January 1, 2017 (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">SEC Reports</font><font style="font-family:inherit;font-size:11pt;">&#8221;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Exchange Act and, in each case, to the rules promulgated thereunder, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The financial statements and the related notes of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with GAAP, except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present the consolidated financial position of the Company as of and for the dates thereof and the consolidated results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. There is no transaction, arrangement, or other relationship between the Company or any Subsidiary and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in SEC Reports and is not so disclosed and would have or reasonably be expected to result in a Material Adverse Effect. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Company is not, and has never been, an issuer identified in Rule 144(i)(1) under the Securities Act. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.10</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Disclosure Controls and Procedures; Internal Controls Over Financial Reporting</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Company has established and maintains disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) that are effective in all material respects to ensure that material information relating to the Company, including any consolidated Subsidiaries, is made known to its principal executive officer and principal financial officer by others within those entities. The Company&#8217;s certifying officers have evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures as of the end of the period covered by the most recently filed quarterly or annual periodic report under the Exchange Act (such date, the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Evaluation Date</font><font style="font-family:inherit;font-size:11pt;">&#8221;). The Company presented in its most recently filed quarterly or annual periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Company maintains internal control over financial reporting (as such term is defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and such internal control over financial reporting is effective. The Company presented in its most recently filed annual report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the Company&#8217;s internal control over financial reporting based on their evaluations as of the end of the period covered by such report. Since the Evaluation Date, there have been no significant changes in the Company&#8217;s internal control over financial reporting or, to the Company&#8217;s knowledge, in other factors that could significantly affect the Company&#8217;s internal control over financial reporting. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.11</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Absence of Litigation</font><font style="font-family:inherit;font-size:11pt;">. There is no claim, action, suit, arbitration, investigation or other proceeding pending against, or to the knowledge of the Company and each Subsidiary, threatened against or affecting, the Company, any Subsidiary or any of the Company&#8217;s or any Subsidiary&#8217;s properties or, to the knowledge of the Company and each Subsidiary, any of its respective officers or directors before any Governmental Entity, in each case other than legal proceedings that are not reasonably expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty relating to the Company or any Subsidiary. There has not been, and to the knowledge of the Company and each Subsidiary, there is not pending or contemplated, any investigation by the Commission of the Company or any Subsidiary or any current or former director or officer of the Company or any Subsidiary. The Company has not received any stop order or other order suspending the effectiveness of any registration statement filed by the Company under the Exchange Act or the Securities Act and, to the Company&#8217;s knowledge, the SEC has not issued any such order. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.12</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Taxes</font><font style="font-family:inherit;font-size:11pt;">. The Company and each Subsidiary has properly filed all federal, foreign, state, local, and other tax returns and reports which are required to be filed by it, which returns and reports were properly completed and are true and correct in all material respects, and all taxes, interest, and penalties due and owing have been timely paid. There are no outstanding waivers or extensions of time with respect to the assessment or audit of any tax or tax return of the Company or any Subsidiary, or claims now pending or matters under discussion between the Company and any taxing authority in respect of any tax of the Company. The Company has no material uncertain tax positions pursuant to FASB Interpretation 48 (FIN 48), Accounting for Uncertainty in Income Taxes. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.13</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Employee Matters</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Company has disclosed in the SEC Reports any &#8220;employee benefit plan&#8221; subject to the Employee Retirement Income Security Act of 1974, as amended (&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">ERISA</font><font style="font-family:inherit;font-size:11pt;">&#8221;), that it or any Subsidiary maintains for employees. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">No director or officer or other employee of the Company or any Subsidiary will become entitled to any retirement, severance, change of control, or similar benefit or enhanced or accelerated benefit (including any acceleration of vesting) or lapse of repurchase rights or obligations with respect to any employee benefit plan subject to ERISA or other benefit under any compensation plan or arrangement of the Company (each, an &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Employee Benefit Plan</font><font style="font-family:inherit;font-size:11pt;">&#8221;) as a result of the transactions contemplated in this Agreement. </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">No executive officer, to the knowledge of the Company and each Subsidiary, is, or is now reasonably expected to be, in violation of any term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant with the Company or any Subsidiary, and, to the knowledge of the Company and each Subsidiary, the continued employment of each such executive officer does not subject the Company or any Subsidiary to any material liability with respect to any of the foregoing matters. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(d)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Company and each Subsidiary is in compliance with all applicable federal, state, local and foreign statutes, laws (including, without limitation, common law), judicial decisions, regulations, ordinances, rules, judgments, orders and codes respecting employment, employment practices, labor, terms and conditions of employment and wages and hours, except where the failure to comply would not have a Material Adverse Effect, and no work stoppage or labor strike against the Company or any Subsidiary is pending or, to their knowledge, threatened, nor is the Company or any Subsidiary involved in or, to their knowledge, threatened with any labor dispute, grievance or litigation relating to labor matters involving any current or former employees of the Company, any Subsidiary or any independent contractors. There are no suits, actions, disputes, claims (other than routine claims for benefits), investigations or audits pending or, to the knowledge of the Company and each Subsidiary, threatened in connection with any Employee Benefit Plan, but excluding any of the foregoing which would not have a Material Adverse Effect. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.14</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Compliance with Laws</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Except as would not result in a Material Adverse Effect: (i) the Company is and has been in compliance with statutes, laws, ordinances, rules and regulations applicable to the Company for the ownership, testing, development, manufacture, packaging, processing, use, labeling, storage, or disposal of any product manufactured by or on behalf of the Company or out-licensed by the Company (a &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Company Product</font><font style="font-family:inherit;font-size:11pt;">&#8221;), including without limitation, the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. &#167; 301, et seq., the Public Health Service Act, 42 U.S.C. &#167; 262, similar laws of other Governmental Entities and the regulations promulgated pursuant to such laws (collectively, &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Applicable Laws</font><font style="font-family:inherit;font-size:11pt;">&#8221;); (ii) the Company possesses all licenses, certificates, approvals, authorizations, permits and supplements or amendments thereto required by any such Applicable Laws and/or for the ownership of its properties or the conduct of its business as it relates to a Company Product and as described in the SEC Reports (collectively, &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Authorizations</font><font style="font-family:inherit;font-size:11pt;">&#8221;) and such Authorizations are valid and in full force and effect and the Company is not in violation of any term of any such Authorizations; (iii) the Company has not received any written notice of adverse finding, warning letter or other written correspondence or notice from the U.S. Food and Drug Administration (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">FDA</font><font style="font-family:inherit;font-size:11pt;">&#8221;) or any other Governmental Entity alleging or asserting noncompliance with any Applicable Laws or Authorizations relating to a Company Product; (iv) the Company has not received written notice of any ongoing claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any Governmental Entity or third party alleging that any Company Product, operation or activity related to a Company Product is in violation of any Applicable Laws or Authorizations or has any knowledge that any such Governmental Entity or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding, nor, to the Company&#8217;s knowledge, has there been any noncompliance with or violation of any Applicable Laws by the Company that would reasonably be expected to require the issuance of any such written notice or result in an investigation, corrective action, or enforcement action by the FDA or similar Governmental Entity with respect to a Company Product; (v) the Company has not received written notice that any Governmental Entity has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorizations or has any knowledge that any such Governmental Entity has threatened or is considering such action with respect to a Company Product; and (vi) the Company has filed, obtained, maintained or submitted all reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete, correct and not misleading on the date filed (or were corrected or supplemented by a subsequent submission).</font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">To the Company&#8217;s knowledge, neither the Company nor any of its directors, officers, employees or agents, has made, or caused the making of, any false statements on, or material omissions from, any other records or documentation prepared or maintained to comply with the requirements of the FDA or any other Governmental Entity. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The clinical studies and tests conducted by the Company or on behalf of the Company, have been and, if still pending, are being conducted in all material respects pursuant to all Applicable Laws and Authorizations; the descriptions of the results of such clinical studies and tests contained in the SEC Reports are accurate and complete in all material respects and fairly present the data derived from such clinical studies and tests; the Company is not aware of any clinical studies or tests, the results of which the Company believes reasonably call into question the research, nonclinical or clinical study or test results described or referred to in the SEC Reports when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from any Governmental Entity requiring the termination, suspension or material modification of any clinical study or test being conducted by or on behalf of the Company. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.15</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Brokers</font><font style="font-family:inherit;font-size:11pt;">. Except for Cantor Fitzgerald &amp; Co., there is no investment banker, broker, finder, financial advisor, placement agent or other Person that has been retained by or is authorized to act on behalf of the Company or any Subsidiary who might be entitled to any fee or commission in connection with the transactions contemplated by this Agreement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.16</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Environmental Matters</font><font style="font-family:inherit;font-size:11pt;">. The Company: (i) is in compliance with any and all applicable foreign, federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Environmental Laws</font><font style="font-family:inherit;font-size:11pt;">&#8221;); (ii) has received and is in compliance with all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct its business; and (iii) has not received notice of any actual or potential liability under any Environmental Law, except in each case where such non-compliance with Environmental Laws, failure to receive required permits, licenses or other approvals, or liability would not, individually or in the aggregate, have a Material Adverse Effect, whether or not arising from transactions in the ordinary course of business. The Company has not been named as a &#8220;potentially responsible party&#8221; under the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.17</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Intellectual Property Matters</font><font style="font-family:inherit;font-size:11pt;">. The Company owns, possesses, licenses or has other rights to use, on reasonable terms, all patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses, inventions, trade secrets, technology, know-how and other intellectual property (collectively, the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Intellectual Property</font><font style="font-family:inherit;font-size:11pt;">&#8221;) necessary for the conduct of the Company&#8217;s business as now conducted or as proposed in the SEC Reports to be conducted (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Company Intellectual Property</font><font style="font-family:inherit;font-size:11pt;">&#8221;). To the knowledge of the Company, there are no rights of third parties to any Company Intellectual Property, other than as licensed by the Company. To the knowledge of the Company, there is no infringement by third parties of any Company Intellectual Property. There is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others challenging the Company&#8217;s rights in or to any Company Intellectual Property. There is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others challenging the validity or scope of any Company Intellectual Property. There is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others that the Company infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary rights of others. The Company is not aware of any facts required to be disclosed to the U.S. Patent and Trademark Office (&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">USPTO</font><font style="font-family:inherit;font-size:11pt;">&#8221;) which have not been disclosed to the USPTO and which would preclude the grant of a patent in connection with any patent application of the Company Intellectual Property or could form the basis of a finding of invalidity with respect to any issued patents of the Company Intellectual Property. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.18</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Absence of Changes</font><font style="font-family:inherit;font-size:11pt;">. Since the Evaluation Date: (a) there has not been any Material Adverse Effect or any event or events that individually or in the aggregate would reasonably be expected to have a Material Adverse Effect; (b) there has not been any dividend or distribution of any kind declared, set aside for payment, paid or made by the Company on any class of capital stock; (c) neither the Company nor any Subsidiary has sustained any material </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">loss or interference with the Company&#8217;s or any Subsidiary&#8217;s business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator or governmental or regulatory authority; and (d) neither the Company nor any Subsidiary has incurred any material liabilities except in the ordinary course of business. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.19</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Suppliers and Customers</font><font style="font-family:inherit;font-size:11pt;">. Neither the Company nor any Subsidiary has any knowledge of any termination, cancellation or threatened termination or cancellation or limitation of, or any material dissatisfaction with, the business relationship between the Company or any Subsidiary and any material supplier, customer, vendor, customer or client. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.20</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Accountants</font><font style="font-family:inherit;font-size:11pt;">. Ernst &amp; Young LLP (&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">E&amp;Y</font><font style="font-family:inherit;font-size:11pt;">&#8221;), who expressed their opinion with respect to the audited financial statements included in the SEC Reports, are independent accountants as required by the Securities Act and the rules and regulations promulgated thereunder. There are no disagreements of any kind presently existing, or reasonably anticipated by the Company to arise, between the Company and E&amp;Y. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.21</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Application of Takeover Protections</font><font style="font-family:inherit;font-size:11pt;">. The Company and its Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Charter Documents or the laws of its state of incorporation (including Section 203 of the Delaware General Corporation Law) that is or could become applicable to each Purchaser as a result of such Purchaser and the Company fulfilling their obligations or exercising their rights under this Agreement, including without limitation as a result of the Company&#8217;s issuance of the Shares and such Purchaser&#8217;s ownership of the Shares. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.22</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Foreign Corrupt Practices</font><font style="font-family:inherit;font-size:11pt;">. Since January 1, 2017, neither the Company, its Subsidiaries, nor to the Company&#8217;s and each Subsidiary&#8217;s knowledge, any director, officer, agent, employee or other person acting on behalf of the Company or any Subsidiary has, in the course of its actions for, or on behalf of, the Company or any Subsidiary (a) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; (b) made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (c) violated or is in violation of in any material respect any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (d) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government official or employee. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.23</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Private Placement</font><font style="font-family:inherit;font-size:11pt;">. Neither the Company nor its Subsidiaries or any affiliates, nor any person acting on its or their behalf, has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under any circumstances that would require registration of the Shares under the Securities Act. Assuming the accuracy of the representations and warranties of the Purchasers contained in Section 4 hereof, the issuance of the Shares are exempt from registration under the Securities Act. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.24</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Insurance</font><font style="font-family:inherit;font-size:11pt;">. The Company is insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as the Company believes are prudent and customary for a company: (a) in the businesses and location in which the Company is engaged; (b) with the resources of the Company; and (c) at a similar stage of development as the Company. The Company has not received any written notice that the Company will not be able to renew its existing insurance coverage as and when such coverage expires. The Company believes it will be able to obtain similar coverage at reasonable cost from similar insurers as may be necessary to continue its business. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.25</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">No Manipulation of Stock</font><font style="font-family:inherit;font-size:11pt;">. The Company has not taken, nor will it take, directly or indirectly, any action designed to stabilize or manipulate the price of the Common Stock or any security of the Company to facilitate the sale or resale of any of the Shares. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">5.26</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Disclosure</font><font style="font-family:inherit;font-size:11pt;">. The Company understands and confirms that the Purchaser will rely on the foregoing representations in effecting transactions in securities of the Company. No representation or warranty by the Company contained in this Agreement contains any untrue statement of a material fact or omits to state any material fact </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. The Company acknowledges and agrees that the Purchaser does not make and has not made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 4 hereof. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Section 6.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Covenants.</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6.01</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Reasonable Best Efforts</font><font style="font-family:inherit;font-size:11pt;">. Each party shall use its reasonable best efforts to timely satisfy each of the conditions to be satisfied by it as provided in Section 7 of this Agreement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6.02</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Reporting Status</font><font style="font-family:inherit;font-size:11pt;">. During the Reporting Period, the Company shall use reasonable best efforts to: (a) timely file all reports required to be filed with the Commission pursuant to the Exchange Act or the rules and regulations thereunder; and (b) not take any action or file any document (whether or not permitted by the Securities Act or the rules promulgated thereunder) to terminate or suspend the Company&#8217;s reporting and filing obligations under the Exchange Act or Securities Act. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6.03</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Use of Proceeds</font><font style="font-family:inherit;font-size:11pt;">. The Company will use the proceeds from the sale of the Shares for research and development of CD101, the Company&#8217;s product candidate, furtherance of the Company&#8217;s Cloudbreak program and general corporate purposes. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6.04</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Pledge of Shares</font><font style="font-family:inherit;font-size:11pt;">. The Company acknowledges and agrees that the Shares may be pledged by the Purchasers in connection with a bona fide margin agreement or other loan or financing arrangement that is secured by the Shares. The pledge of Shares shall not be deemed to be a transfer, sale or assignment of the Shares hereunder, and in effecting a pledge of Shares the Purchasers shall not be required to provide the Company with any notice thereof or otherwise make any delivery to the Company pursuant to this Agreement. The Company hereby agrees to execute and deliver such documentation as a pledgee of the Shares may reasonably request in connection with a pledge of the Shares to such pledgee by the Purchasers. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6.05</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Disclosure of Transactions and Other Material Information</font><font style="font-family:inherit;font-size:11pt;">. On or before 8:30 a.m., New York City time, on the second Business Day following the date of this Agreement, the Company shall issue a press release and file a Current Report on Form 8-K describing the terms and conditions of the transactions contemplated by the Transaction Documents in the form required by the Exchange Act and attaching the Agreement as an exhibit to such filing (including all attachments, the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">8-K Filing</font><font style="font-family:inherit;font-size:11pt;">&#8221;). The Company shall not publicly disclose the name of any Purchaser or any affiliate or investment adviser of the Purchaser, or include the name of any Purchaser or any affiliate or investment adviser of the Purchaser in any filing with the Commission (other than in a Registration Statement and any exhibits to filings made in respect of this transaction in accordance with periodic report or current report filing requirements under the Exchange Act) or any regulatory agency, without the prior written consent of such Purchaser, except to the extent such disclosure is required by law or regulations, in which case the Company shall provide each Purchaser whose name is to be disclosed with prior notice of such disclosure and a reasonable opportunity to comment on the proposed disclosure insofar as it relates specifically to such Purchaser. Subject to the foregoing, neither the Company nor the Purchasers shall issue any press releases or any other public statements with respect to the transactions contemplated hereby; provided, however, that the Company shall be entitled, without the prior approval of the Purchasers, to make any press release or other public disclosure with respect to such transactions (a) in substantial conformity with the 8-K Filing and contemporaneously therewith and (b) as is required by Applicable Law. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6.06</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Short Sales</font><font style="font-family:inherit;font-size:11pt;">. Each Purchaser covenants that neither it nor any Affiliates acting on its behalf or pursuant to any understanding with it will execute any Short Sales during the period from the date hereof until the earlier of such time as: (a) after the transactions contemplated by this Agreement are first publicly announced; or (b) this Agreement is terminated in full. Except: (i) as required by Applicable Law or the listing rules of any applicable national or regional securities exchange; (ii) as required to be disclosed in filings or other submissions to any court, regulatory body, administrative agency, governmental body, arbitrator or other legal authority having jurisdiction </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">11.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">over a party hereto made to obtain necessary consents, approvals or filings; or (iii) as provided by the terms and provisions of the existing confidentiality and non-use obligations of the parties hereto, each Purchaser covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company, such Purchaser will maintain the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Each Purchaser understands and acknowledges that the Commission currently takes the position that coverage of Short Sales of shares of the Common Stock &#8220;against the box&#8221; prior to effectiveness of a resale registration statement with securities included in such registration statement would be a violation of Section 5 of the Securities Act, as set forth in Item 239.10 of the Securities Act Rules Compliance and Disclosure Interpretations compiled by the Office of Chief Counsel, Division of Corporation Finance. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6.07</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Expenses</font><font style="font-family:inherit;font-size:11pt;">. The Company and each Purchaser is liable for, and will pay, its own expenses incurred in connection with the negotiation, preparation, execution and delivery of this Agreement, including, without limitation, attorneys&#8217; and consultants&#8217; fees and expenses. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Section 7.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Conditions of Parties&#8217; Obligations</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7.01</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Conditions of the Purchasers&#8217; Obligations at the Closing</font><font style="font-family:inherit;font-size:11pt;">. The obligations of the Purchasers under Section 2 hereof are subject to the fulfillment, prior to the Closing, of all of the following applicable conditions, any of which may be waived in whole or in part by the Purchasers in their absolute discretion. If the following conditions are not satisfied on or before 5:00 p.m. (Eastern Time) on the 10</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;Business Day following the Effective Date (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Outside Date</font><font style="font-family:inherit;font-size:11pt;">&#8221;), then any Purchaser may terminate this Agreement with respect to that particular Purchaser upon providing written notice to the Company. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Representations and Warranties</font><font style="font-family:inherit;font-size:11pt;">. The representations and warranties of the Company contained in this Agreement and in any certificate, if any, or other writing, if any, delivered by the Company pursuant hereto shall be true and correct on and as of the Closing Date with the same effect as though such representations and warranties had been made on and as of the Closing Date (except to the extent expressly made as of an earlier date in which case as of such earlier date). </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Performance</font><font style="font-family:inherit;font-size:11pt;">. The Company shall have performed and complied in all material respects with all covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied by it on or prior to the Closing Date. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Delivery</font><font style="font-family:inherit;font-size:11pt;">. The Company shall deliver this Agreement duly executed by the Company. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(d)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Qualification under State Securities Laws</font><font style="font-family:inherit;font-size:11pt;">. All registrations, qualifications, permits and approvals, if any, required under applicable state securities laws shall have been obtained for the lawful execution, delivery and performance of this Agreement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(e)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Consents and Waivers</font><font style="font-family:inherit;font-size:11pt;">. The Company shall have obtained all consents or waivers necessary to execute and perform its obligations under this Agreement. All corporate and other action and governmental filings necessary for the Company to effectuate the terms of this Agreement and other agreements and instruments executed and delivered by the Company in connection herewith shall have been made or taken by the Company, and no Material Adverse Effect has occurred with respect to the operation of the Company&#8217;s business. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(f)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Transfer Agent Instructions</font><font style="font-family:inherit;font-size:11pt;">. The Company shall have delivered to its transfer agent irrevocable written instructions to issue to such Purchaser (or in such nominee&#8217;s name(s) as designated by such Purchaser) one or more certificates representing such Shares set forth opposite such Purchaser&#8217;s name on </font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Schedule&#160;I </font><font style="font-family:inherit;font-size:11pt;">hereto (or book-entry notations in lieu of such certificates); provided, however, that if such Purchaser has indicated to the Company at the time of execution of this Agreement a need to settle &#8220;delivery versus payment,&#8221; the Company shall deliver to such Purchaser (or such Purchaser&#8217;s designated custodian) such original stock certificates to be acquired </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">12.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">by such Purchaser (or written confirmation that such Shares have been issued in the Purchaser&#8217;s name via book-entry notation). </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(g)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Absence of Litigation</font><font style="font-family:inherit;font-size:11pt;">. No proceeding challenging this Agreement or the transactions contemplated hereby, or seeking to prohibit, alter, prevent or materially delay the Closing, shall have been instituted or be pending before any court, arbitrator, governmental body, agency or official. The sale of the Shares by the Company shall not be prohibited by any law or governmental order or regulation. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">7.02</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Conditions of the Company&#8217;s Obligations</font><font style="font-family:inherit;font-size:11pt;">. The obligations of the Company under Section 2 hereof are subject to the fulfillment prior to or on the Closing Date of all of the following conditions, any of which may be waived in whole or in part by the Company: (a) each Purchaser at the Closing shall have performed all of its obligations hereunder required to be performed by it at or prior to the Closing; and (b) the representations and warranties of the Purchasers at the Closing contained in this Agreement shall be true and correct at and as of the Closing as if made at and as of the Closing (except to the extent expressly made as of an earlier date, in which case as of such earlier date). If the foregoing conditions are not satisfied on or the Outside Date, then the Company may terminate this Agreement upon providing written notice to the Purchasers. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Section 8.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Transfer Restrictions; Restrictive Legend</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8.01</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Transfer Restrictions</font><font style="font-family:inherit;font-size:11pt;">. The Purchasers understand that the Company may, as a condition to the transfer of any of the Shares, require that the request for transfer be accompanied by an opinion of counsel reasonably satisfactory to the Company, to the effect that the proposed transfer does not result in a violation of the Securities Act, unless such transfer is covered by an effective registration statement or by Rule 144 or Rule 144A under the Securities Act; provided, however, that an opinion of counsel shall not be required for a transfer by a Purchaser that is: (A) a partnership transferring to its partners or former partners in accordance with partnership interests; (B) a corporation transferring to a wholly owned subsidiary or a parent corporation that owns all of the capital stock of such Purchaser; (C) a limited liability company transferring to its members or former members in accordance with their interest in the limited liability company; (D) an individual transferring to such Purchaser&#8217;s family member or trust for the benefit of an individual Purchaser; (E) transferring its Shares to any Affiliate of such Purchaser, in the case of an institutional investor, or other Person under common management with such Purchaser; or (F) a transfer that is made pursuant to a bona fide gift to a third party; provided, further, that (i) the transferee in each case agrees to be subject to the restrictions in this Section 8 and provides the Company with a representation letter containing customary investment representations under the Securities Act, (ii) the Company satisfies itself that the number of transferees is sufficiently limited and (iii) in the case of transferees that are partners or limited liability company members, the transfer is for no consideration. It is understood that the certificates evidencing the Shares may bear substantially the following legend: </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY APPLICABLE STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER SUCH ACT OR APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED OR UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A OF SUCH ACT.&#8221; </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">8.02</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Unlegended Certificates</font><font style="font-family:inherit;font-size:11pt;">. The Company shall, at its sole expense, upon appropriate notice from any Purchaser stating that Registrable Securities have been sold pursuant to an effective Registration Statement, timely prepare and deliver certificates representing the Shares to be delivered to a transferee pursuant to the Registration Statement, which certificates shall be free of any restrictive legends and in such denominations and registered in such names as such Purchaser may request. Further, the Company shall, at its sole expense, cause its legal counsel or other counsel satisfactory to the transfer agent to provide all opinions as may reasonably be required by the transfer agent in connection with the removal of legends. A Purchaser may request that the Company remove, and the Company agrees to authorize the removal of, any legend from such Shares, following the delivery by a Purchaser to the Company </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">13.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">or the Company&#8217;s transfer agent of a legended certificate representing such Shares: (i) following any sale of such Shares pursuant to Rule 144, (ii) if such Shares are eligible for sale under Rule 144(b)(1), or (iii) following the time a legend is no longer required with respect to such Shares. If a legend is no longer required pursuant to the foregoing, the Company will, no later than three Business Days following the delivery by a Purchaser to the Company or the Company&#8217;s transfer agent of a legended certificate representing such Shares, deliver or cause to be delivered to such Purchaser a certificate representing such Shares that is free from all restrictive legends. Certificates for Shares free from all restrictive legends may be transmitted by the Company&#8217;s transfer agent to the Purchasers by crediting the account of the Purchaser&#8217;s prime broker with the Depository Trust Company (&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">DTC</font><font style="font-family:inherit;font-size:11pt;">&#8221;) as directed by such Purchaser. The Company warrants that the Shares shall otherwise be freely transferable on the books and records of the Company as and to the extent provided in this Agreement. If a Purchaser effects a transfer of the Shares in accordance with Section 8.01, the Company shall permit the transfer and shall promptly instruct its transfer agent to issue one or more certificates or credit shares to the applicable balance accounts at DTC in such name and in such denominations as specified by such Purchaser to effect such transfer. Each Purchaser hereby agrees that the removal of the restrictive legend pursuant to this Section 8.02 is predicated upon the Company&#8217;s reliance that such Purchaser will sell any such Shares pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption therefrom. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Section 9.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Registration, Transfer and Substitution of Certificates for Shares</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9.01</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Stock Register; Ownership of Shares</font><font style="font-family:inherit;font-size:11pt;">. The Company will keep at its principal office, or will cause its transfer agent to keep, a register in which the Company will provide for the registration of transfers of the Shares. The Company may treat the Person in whose name any of the Shares are registered on such register as the owner thereof and the Company shall not be affected by any notice to the contrary. All references in this Agreement to a &#8220;holder&#8221; of any Shares shall mean the Person in whose name such Shares are at the time registered on such register. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">9.02</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Replacement of Certificates</font><font style="font-family:inherit;font-size:11pt;">. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of any certificate representing any of the Shares, and, in the case of any such loss, theft or destruction, upon delivery of an indemnity agreement and surety bond reasonably satisfactory to the Company or, in the case of any such mutilation, upon surrender of such certificate for cancellation at the office of the Company maintained pursuant to Section 9.01 hereof, the Company at its expense will execute and deliver, in lieu thereof, a new certificate representing such Shares, of like tenor. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Section 10.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Registration Rights of Purchasers</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10.01</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Mandatory Registration</font><font style="font-family:inherit;font-size:11pt;">. The Company shall prepare, and, as soon as practicable but in no event later than 45 days after the Closing Date (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Filing Deadline</font><font style="font-family:inherit;font-size:11pt;">&#8221;), file with the Commission a Registration Statement under the Securities Act on appropriate form covering the resale of the full amount of the Shares (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Registrable Securities</font><font style="font-family:inherit;font-size:11pt;">&#8221;). The Company shall use its commercially reasonable efforts to have the Registration Statement declared effective by the Commission as soon as practicable, but in no event later than the date (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Effectiveness Deadline</font><font style="font-family:inherit;font-size:11pt;">&#8221;), which shall be either: (i) in the event that the Commission does not review the Registration Statement, 90 days after the Closing Date, or (ii) in the event that the Commission reviews the Registration Statement, 120 days after the Closing Date (but in any event, no later than three Business Days following the Commission indicating that it has no further comments on the Registration Statement). Subject to any comments from the staff of the Commission (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Staff</font><font style="font-family:inherit;font-size:11pt;">&#8221;), such Registration Statement shall include the plan of distribution attached hereto as </font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Exhibit A</font><font style="font-family:inherit;font-size:11pt;">; provided, however, that no Purchaser shall be named as an &#8220;underwriter&#8221; in the Registration Statement without the Purchaser&#8217;s prior written consent. Such Registration Statement shall not include any shares of Common Stock or other securities for the account of any other holder without the prior written consent of the Required Holders. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10.02</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Rule 415; Cutback</font><font style="font-family:inherit;font-size:11pt;">. If at any time the Staff takes the position that the offering of some or all of the Registrable Securities in a Registration Statement is not eligible to be made on a delayed or continuous basis under the provisions of Rule 415 under the Securities Act or requires any Purchaser to be named as an &#8220;underwriter,&#8221; the Company shall use its reasonable best efforts to persuade the Commission that the offering contemplated by the </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">14.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Registration Statement is a valid secondary offering and not an offering &#8220;by or on behalf of the issuer&#8221; as defined in Rule 415 and that none of the Purchasers is an &#8220;underwriter.&#8221; In the event that, despite the Company&#8217;s reasonable best efforts and compliance with the terms of this Section 10.02, the Staff refuses to alter its position, the Company shall (i) remove from the Registration Statement such portion of the Registrable Securities (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Cut Back Shares</font><font style="font-family:inherit;font-size:11pt;">&#8221;) and/or (ii) agree to such restrictions and limitations on the registration and resale of the Registrable Securities as the Staff may require to assure the Company&#8217;s compliance with the requirements of Rule 415 (collectively, the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">SEC Restrictions</font><font style="font-family:inherit;font-size:11pt;">&#8221;); provided, however, that the Company shall not agree to name any Purchaser as an &#8220;underwriter&#8221; in such Registration Statement without the prior written consent of such Purchaser. Any cutback imposed on the Purchasers pursuant to this Section 10.02 shall be allocated among the Purchasers on a pro rata basis, unless the SEC Restrictions otherwise require or provide or the Purchasers otherwise agree. No liquidated damages shall accrue as to any Cut Back Shares until such date as the Company is able to effect the registration of such Cut Back Shares in accordance with any SEC Restrictions (such date, the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Restriction Termination Date</font><font style="font-family:inherit;font-size:11pt;">&#8221; of such Cut Back Shares). From and after the Restriction Termination Date applicable to any Cut Back Shares, all of the provisions of this Section 10 (including the liquidated damages provisions) shall again be applicable to such Cut Back Shares; provided, however, that (x) the Filing Deadline for the Registration Statement including such Cut Back Shares shall be 10 Business Days after such Restriction Termination Date, and (y) the Effectiveness Deadline with respect to such Cut Back Shares shall be the 90th day immediately after the Restriction Termination Date or the 120th day if the Staff reviews such Registration Statement (but in any event no later than three Business Days from the Staff indicating it has no further comments on such Registration Statement). </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10.03</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Effect of Failure to File and Obtain and Maintain Effectiveness of Registration Statement</font><font style="font-family:inherit;font-size:11pt;">. Subject to Section 10.02, if either: (a) a Registration Statement covering all of the Registrable Securities required to be covered thereby and required to be filed by the Company pursuant to this Agreement is (i) not filed with the Commission on or before the Filing Deadline (a &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Filing Failure</font><font style="font-family:inherit;font-size:11pt;">&#8221;) or (ii) not declared effective by the Commission on or before the Effectiveness Deadline (an &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Effectiveness Failure</font><font style="font-family:inherit;font-size:11pt;">&#8221;); or (b) on any day during the Reporting Period and after the Effectiveness Date, sales of all of the Registrable Securities required to be included on such Registration Statement cannot be made (other than (i) during an Allowable Grace Period or (ii) if the Registration Statement is on Form S-1, for a period of 15 days following the date the Company files a post-effective amendment to incorporate the Company&#8217;s Annual Report on Form 10-K) pursuant to such Registration Statement (including, without limitation, because of a failure to keep such Registration Statement effective, to disclose such information as is necessary for sales to be made pursuant to such Registration Statement or to register a sufficient number of shares of Common Stock) (a &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Maintenance Failure</font><font style="font-family:inherit;font-size:11pt;">&#8221;), then, in satisfaction of the damages to any holder of Registrable Securities by reason of any such delay in or reduction of its ability to sell the underlying shares of Common Stock, the Company shall pay to each holder of Registrable Securities relating to such Registration Statement an amount in cash equal to 1.0% of such holder&#8217;s Pro Rata Interest in the Aggregate Purchase Price on each of the following dates: (x) the day of a Filing Failure and on every 30</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;day (prorated for periods totaling less than 30 days) thereafter until such Filing Failure is cured; (y) the day of an Effectiveness Failure and on every 30</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th</sup></font><font style="font-family:inherit;font-size:11pt;">&#160;day (prorated for periods totaling less than 30 days) thereafter until such Effectiveness Failure is cured; and (z) the initial day of a Maintenance Failure and on every 30</font><font style="font-family:inherit;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th</sup></font><font style="font-family:inherit;font-size:11pt;">&#32;day (prorated for periods totaling less than 30 days) thereafter until such Maintenance Failure is cured. The payments to which a holder shall be entitled pursuant to this Section 10.03 are referred to herein as &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Registration Delay Payments</font><font style="font-family:inherit;font-size:11pt;">;&#8221; provided that no Registration Delay Payments shall be required following the termination of the Reporting Period, and provided further that in no event shall the aggregate Registration Delay Payments accruing under this Section 10.03 exceed 6% of a holder&#8217;s Pro Rata Interest in the Aggregate Purchase Price (i.e., corresponding to a total delay of six months). The first such Registration Delay Payment shall be paid within three Business Days after the event or failure giving rise to such Registration Delay Payment occurred and all other Registration Delay Payments shall be paid on the earlier of (I) the last day of the calendar month during which such Registration Delay Payments are incurred and (II) the third Business Day after the event or failure giving rise to the Registration Delay Payments is cured. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10.04</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Related Obligations</font><font style="font-family:inherit;font-size:11pt;">. At such time as the Company is obligated to file a Registration Statement with the Commission pursuant to Section 10.01 hereof, the Company will use commercially reasonable efforts to effect </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">15.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">the registration of the Registrable Securities in accordance with the intended method of disposition thereof and, pursuant thereto, the Company shall have the following obligations: </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Company shall submit to the Commission, within three Business Days after the Company learns that no review of a particular Registration Statement will be made by the staff of the Commission or that the staff has no further comments on a particular Registration Statement, as the case may be, a request for acceleration of effectiveness of such Registration Statement to a time and date not later than two Business Days after the submission of such request. The Company shall keep each Registration Statement effective pursuant to Rule 415 at all times with respect to each Purchaser&#8217;s Registrable Securities until the expiration of the Reporting Period. The Company shall ensure that each Registration Statement (including any amendments or supplements thereto and prospectuses contained therein) shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein (in the case of prospectuses, in the light of the circumstances in which they were made) not misleading. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Company shall prepare and file with the Commission such amendments (including post-effective amendments) and supplements to a Registration Statement and the prospectus used in connection with such Registration Statement, which prospectus is to be filed pursuant to Rule 424 promulgated under the Securities Act, as may be necessary to keep such Registration Statement effective at all times during the Reporting Period, and, during such period, comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities of the Company covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance with the intended methods of disposition by the seller or sellers thereof as set forth in such Registration Statement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Upon request of a Purchaser, the Company shall furnish to such Purchaser without charge, (i) promptly after the Registration Statement including such Purchaser&#8217;s Registrable Securities is prepared and filed with the Commission, at least one copy of such Registration Statement and any amendment(s) thereto, including financial statements and schedules, all documents incorporated therein by reference, and if requested by the Purchaser, all exhibits and each preliminary prospectus, (ii) upon the effectiveness of any Registration Statement, 10 copies of the prospectus included in such Registration Statement and all amendments and supplements thereto (or such other number of copies as the Purchaser may reasonably request) and (iii) such other documents, including copies of any preliminary or final prospectus, as the Purchaser may reasonably request from time to time in order to facilitate the disposition of the Registrable Securities.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(d)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Company shall notify the Purchasers in writing of the happening of any event, as promptly as practicable after becoming aware of such event, as a result of which the prospectus included in a Registration Statement, as then in effect, includes an untrue statement of a material fact or omission to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading (provided that in no event shall such notice contain any material, nonpublic information), and promptly prepare a supplement or amendment to such Registration Statement to correct such untrue statement or omission, and upon request deliver 10 copies of such supplement or amendment to the Purchasers (or such other number of copies as the Purchasers may reasonably request). Unless such information is publicly available, the Company shall also promptly notify the Purchasers in writing (i) when a prospectus or any prospectus supplement or post-effective amendment has been filed, and when a Registration Statement or any post-effective amendment has become effective (notification of such effectiveness shall be delivered to the Purchasers by facsimile or email on the same day of such effectiveness), (ii) of any request by the Commission for amendments or supplements to a Registration Statement or related prospectus or related information, and (iii) of the Company&#8217;s reasonable determination that a post-effective amendment to a Registration Statement would be appropriate. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(e)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Company shall use commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness of a Registration Statement, or the suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment and to notify the Purchaser who holds Registrable </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">16.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Securities being sold of the issuance of such order and the resolution thereof or its receipt of notice of the initiation or threat of any proceeding for such purpose. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(f)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">If a Purchaser is required under applicable securities law to be described in the Registration Statement as an underwriter, at the reasonable request of the Purchaser, the Company shall furnish to the Purchaser, on the date of the effectiveness of the Registration Statement and thereafter from time to time on such dates as the Purchaser may reasonably request, (i) a letter, dated such date, from the Company&#8217;s independent certified public accountants in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the Purchaser, and (ii) an opinion, dated as of such date, of counsel representing the Company for purposes of such Registration Statement, in form, scope and substance as is customarily given in an underwritten public offering, addressed to the Purchaser. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(g)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">If a Purchaser is required under applicable securities law to be described in the Registration Statement as an underwriter, upon the written request of the Purchaser in connection with the Purchaser&#8217;s due diligence requirements, if any, the Company shall make available for inspection by (i) the Purchaser and its legal counsel and (ii) one firm of accountants or other agents retained by the Purchaser (collectively, the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Inspectors</font><font style="font-family:inherit;font-size:11pt;">&#8221;), all pertinent financial and other records, and pertinent corporate documents and properties of the Company (collectively, the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Records</font><font style="font-family:inherit;font-size:11pt;">&#8221;), as shall be reasonably deemed necessary by each Inspector solely for the purpose of establishing a due diligence defense under underwriter liability under the Securities Act, and cause the Company&#8217;s officers, directors and employees to supply all information which any Inspector may reasonably request; provided, however, that each Inspector shall agree to hold in strict confidence and shall not make any disclosure (except to the Purchaser) or use of any Record or other information which the Company determines in good faith to be confidential, and of which determination the Inspectors are so notified, unless (a) the disclosure of such Records is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required under the Securities Act, (b) the release of such Records is ordered pursuant to a final, non-appealable subpoena or order from a court or government body of competent jurisdiction, or (c) the information in such Records has been made generally available to the public other than by disclosure in violation of this Agreement or any other agreement. The Purchaser agrees that it shall, upon learning that disclosure of such Records is sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt notice to the Company and allow the Company, at its expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order preventing disclosure of, the Records deemed confidential. Nothing herein (or in any other confidentiality agreement between the Company and the Purchaser) shall be deemed to limit the Purchaser&#8217;s ability to sell Registrable Securities in a manner which is otherwise consistent with Applicable Laws. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(h)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Company shall hold in confidence and not make any disclosure of information concerning the Purchasers provided to the Company unless (i) disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information is necessary to avoid or correct a misstatement or omission in any Registration Statement, (iii) the release of such information is ordered pursuant to a subpoena or other final, non-appealable order from a court or governmental body of competent jurisdiction or (iv) such information has been made generally available to the public other than by disclosure in violation of this Agreement or any other agreement. The Company agrees that it shall, upon learning that disclosure of such information concerning the Purchasers is sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt written notice to the Purchasers and allow the Purchasers, at each Purchaser&#8217;s expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order preventing disclosure of, such information. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(i)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Company shall cooperate with the Purchasers and, to the extent applicable, facilitate the timely preparation and delivery of certificates (not bearing any restrictive legend) representing the Registrable Securities to be offered pursuant to a Registration Statement and enable such certificates to be in such denominations or amounts, as the case may be, as the Purchasers may reasonably request and registered in such names as the Purchasers may request. </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">17.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(j)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">If requested by a Purchaser, the Company shall, as soon as practicable, (i) incorporate in a prospectus supplement or post-effective amendment such information as the Purchaser reasonably requests to be included therein relating to the sale and distribution of Registrable Securities, including, without limitation, information with respect to the number of Registrable Securities being offered or sold, the purchase price being paid therefor and any other terms of the offering of the Registrable Securities to be sold in such offering; (ii) make all required filings of such prospectus supplement or post-effective amendment after being notified of the matters to be incorporated in such prospectus supplement or post-effective amendment; and (iii) supplement or make amendments to any Registration Statement if reasonably requested by the Purchaser. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(k)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Company shall use commercially reasonable efforts to cause the Registrable Securities covered by a Registration Statement to be registered with or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable Securities. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(l)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">The Company shall otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission in connection with any registration hereunder. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(m)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Within two Business Days after a Registration Statement that covers Registrable Securities is declared effective by the Commission, the Company shall deliver to the transfer agent for such Registrable Securities (with copies to the Purchasers) confirmation that such Registration Statement has been declared effective by the Commission. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(n)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Notwithstanding anything to the contrary herein, at any time after the Effectiveness Date, the Company may delay the disclosure of material, non-public information concerning the Company the disclosure of which at the time is not, in the good faith opinion of the Board of Directors and its counsel, in the best interest of the Company and, in the opinion of counsel to the Company, otherwise required (a &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Grace Period</font><font style="font-family:inherit;font-size:11pt;">&#8221;); provided, that the Company shall promptly (i) notify the Purchasers in writing of the existence of material, non-public information giving rise to a Grace Period (provided that in each notice the Company will not disclose the content of such material, non-public information to the Purchasers) and the date on which the Grace Period will begin, and (ii) notify the Purchasers in writing of the date on which the Grace Period ends; and, provided further, that the Grace Periods shall not exceed an aggregate of 30 Trading Days during any 365-day period and the first day of any Grace Period must be at least 15 days after the last day of any prior Grace Period (each, an &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Allowable Grace Period</font><font style="font-family:inherit;font-size:11pt;">&#8221;). For purposes of determining the length of a Grace Period above, the Grace Period shall begin on and include the date the Purchasers receive the notice referred to in clause (i) and shall end on and include the later of the date the Purchasers receive the notice referred to in clause (ii) and the date referred to in such notice. The provisions of Section 10.04(d) hereof shall not be applicable during the period of any Allowable Grace Period. Upon expiration of the Grace Period, the Company shall again be bound by the first sentence of Section 10.04(c) with respect to the information giving rise thereto unless such material, non-public information is no longer applicable. Notwithstanding anything to the contrary, the Company shall cause its transfer agent to deliver unlegended shares of Common Stock to a transferee of any Purchaser in accordance with the terms of this Agreement in connection with any sale of Registrable Securities with respect to which a Purchaser has entered into a contract for sale, and delivered a copy of the prospectus included as part of the applicable Registration Statement (unless an exemption from such prospectus delivery requirement exists), prior to the Purchaser&#8217;s receipt of the notice of a Grace Period and for which the Purchaser has not yet settled. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(o)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Neither the Company nor any Subsidiary or affiliate thereof shall identify any Purchaser as an underwriter in any public disclosure or filing with the Commission or any applicable Trading Market without the prior written consent of such Purchaser, and any Purchaser being deemed an underwriter by the Commission shall not relieve the Company of any obligations it has under this Agreement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10.05</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Obligations of the Purchasers</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">At least five Business Days prior to the first anticipated filing date of a Registration Statement, the Company shall notify each Purchaser in writing of any information the Company requires from such Purchaser </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">18.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">in order to have that Purchaser&#8217;s Registrable Securities included in such Registration Statement. It shall be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect to the Registrable Securities of a particular Purchaser that the Purchaser shall furnish to the Company such information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it as shall be reasonably required to effect the effectiveness of the registration of such Registrable Securities and shall execute such documents in connection with such registration as the Company may reasonably request. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Each Purchaser, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of any Registration Statement hereunder, unless the Purchaser has notified the Company in writing of the Purchaser&#8217;s election to exclude all of the Purchaser&#8217;s Registrable Securities from such Registration Statement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Each Purchaser agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 10.04(d) or the first sentence of Section 10.04(c), the Purchaser will immediately discontinue disposition of Registrable Securities pursuant to any Registration Statement(s) covering such Registrable Securities until the Purchaser&#8217;s receipt of the copies of the supplemented or amended prospectus contemplated by Section 10.04(d) or the first sentence of Section 10.04(c) or receipt of notice that no supplement or amendment is required. Notwithstanding anything to the contrary, the Company shall cause its transfer agent to deliver unlegended shares of Common Stock to a transferee of the Purchaser in accordance with the terms of this Agreement in connection with any sale of Registrable Securities with respect to which the Purchaser has entered into a contract for sale prior to the Purchaser&#8217;s receipt of a notice from the Company of the happening of any event of the kind described in Section 10.04(d) or the first sentence of Section 10.04(c) and for which the Purchaser has not yet settled. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(d)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">Each Purchaser covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it or an exemption therefrom in connection with sales of Registrable Securities pursuant to the Registration Statement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10.06</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Expenses of Registration</font><font style="font-family:inherit;font-size:11pt;">. All reasonable expenses incurred in connection with registrations, filings or qualifications pursuant to this Section 10, including, without limitation, all registration, listing and qualifications fees, printers and accounting fees, and fees and disbursements of counsel for the Company, shall be paid by the Company. Notwithstanding the foregoing, in no event shall the Company be responsible for underwriting discounts, commissions, placement agent fees or other similar expenses payable with respect to Registrable Securities being sold or offered for sale by the Purchasers. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10.07</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Reports under the Exchange Act</font><font style="font-family:inherit;font-size:11pt;">. With a view to making available to the Purchasers the benefits of Rule 144 promulgated under the Securities Act or any other similar rule or regulation of the Commission that may at any time permit the Purchasers to sell securities of the Company to the public without registration (&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Rule 144</font><font style="font-family:inherit;font-size:11pt;">&#8221;), the Company agrees to: </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">make and keep public information available, as those terms are understood and defined in Rule 144, during the Reporting Period; </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">file with the Commission in a timely manner all reports and other documents required of the Company under the Exchange Act; and </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;">furnish to the Purchasers, so long as any Purchaser owns Registrable Securities, promptly upon request during the Reporting Period: (i) a written statement by the Company, if true, that it has complied with the reporting requirements of Rule 144, the Securities Act and the Exchange Act, (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii) such </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">19.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">other information as may be reasonably requested to permit the Purchasers to sell such securities pursuant to Rule 144 without registration. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10.08</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Assignment of Registration Rights</font><font style="font-family:inherit;font-size:11pt;">. The rights under Section 10 shall be automatically assignable by a Purchaser to any transferee of all or any portion of the Purchaser&#8217;s Registrable Securities if: (i) the Purchaser agrees in writing with the transferee or assignee to assign such rights and a copy of such agreement is furnished to the Company within a reasonable time after such assignment; (ii) the Company is, within a reasonable time after such transfer or assignment, furnished with written notice of (a) the name and address of such transferee or assignee and (b) the securities with respect to which such registration rights are being transferred or assigned; (iii) immediately following such transfer or assignment the further disposition of such securities by the transferee or assignee is restricted under the Securities Act or applicable state securities laws; (iv) at or before the time the Company receives the written notice contemplated by clause (ii) of this sentence the transferee or assignee agrees in writing with the Company to be bound by all of the provisions contained herein; and (v) such transfer shall have been made in accordance with the applicable requirements of this Agreement. Following any such transfer in accordance with this Section 10.08, the Company shall thereafter use commercially reasonable efforts to amend or supplement the selling stockholder table contained in the Registration Statement to reflect such change in beneficial ownership of the affected Registrable Securities. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">10.09</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Indemnification</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(a)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Company Indemnification</font><font style="font-family:inherit;font-size:11pt;">. The Company will indemnify each Purchaser who holds Registrable Securities (if Registrable Securities held by such Purchaser are included in the securities as to which such registration is being effected), each of its officers and directors, partners, members and each person controlling such Purchaser within the meaning of Section 15 of the Securities Act, against all expenses, claims, losses, damages or liabilities (or actions in respect thereof), including any of the foregoing incurred in settlement of any litigation, commenced or threatened, arising out of or based on (A) any untrue statement (or alleged untrue statement) of a material fact contained in any Registration Statement, prospectus, offering circular or other document, or any amendment or supplement thereto, incident to any such Registration Statement, or based on any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, or (B) any violation by the Company of the Securities Act, the Exchange Act, state securities laws or any rule or regulation promulgated under such laws applicable to the Company in connection with any such registration; and in each case, the Company will reimburse each such Purchaser, each of its officers and directors, partners, members and each person controlling such Purchaser, for any legal and any other expenses reasonably incurred, as such expenses are incurred, in connection with investigating, preparing or defending any such claim, loss, damage, liability or action, provided that the Company will not be liable in any such case to the extent that any such claim, loss, damage, liability or expense arises out of or is based on (X) any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with written information furnished to the Company by an instrument duly executed by such Purchaser or controlling person, and stated to be specifically for use therein, (Y) the use by a Purchaser of an outdated or defective prospectus after the Company has notified such Purchaser in writing that the prospectus is outdated or defective or (Z) a Purchaser&#8217;s (or any other indemnified person&#8217;s) failure to send or give a copy of the prospectus or supplement (as then amended or supplemented), if required, pursuant to Rule 172 under the Securities Act (or any successor rule) to the Persons asserting an untrue statement or alleged untrue statement or alleged untrue statement or omission or alleged omission at or prior to the written confirmation of the sale of Registrable Securities to such person if such statement or omission was corrected in such prospectus or supplement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(b)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Purchaser Indemnification</font><font style="font-family:inherit;font-size:11pt;">. Each Purchaser holding Registrable Securities will, if Registrable Securities held by such Purchaser are included in the securities as to which such registration is being effected, severally and not jointly, indemnify the Company, each of its directors and officers, other holders of the Company&#8217;s securities covered by such Registration Statement, each person who controls the Company within the meaning of Section 15 of the Securities Act, and each such holder, each of its officers and directors and each person controlling such holder within the meaning of Section 15 of the Securities Act, against all claims, losses, damages and liabilities (or actions </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">20.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">in respect thereof) arising out of or based on: (A) any untrue statement (or alleged untrue statement) of a material fact contained in any such Registration Statement, prospectus, offering circular or other document, or any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, to the extent, and only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such Registration Statement, prospectus, offering circular or other document in reliance upon and in conformity with written information furnished to the Company by an instrument duly executed by such Purchaser and stated to be specifically for use therein, or (B) any violation by such Purchaser of the Securities Act, the Exchange Act, state securities laws or any rule or regulation promulgated under such laws applicable to such Purchaser, and in each case, such Purchaser will reimburse the Company, each other holder, and directors, officers, persons, underwriters or control persons of the Company and the other holders for any legal or any other expenses reasonably incurred, as such expenses are incurred, in connection with investigating or defending any such claim, loss, damage, liability or action; provided, that the indemnity agreement contained in this Subsection 10.09(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of such indemnifying Purchaser (which consent shall not be unreasonably withheld or delayed). The liability of any Purchaser for indemnification under this Subsection 10.09(b) in its capacity as a seller of Registrable Securities shall not exceed the amount of net proceeds to such Purchaser of the securities sold in any such registration. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(c)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Notice and Procedure</font><font style="font-family:inherit;font-size:11pt;">. Each party entitled to indemnification under this Section 10.09 (each, an &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Indemnified Party</font><font style="font-family:inherit;font-size:11pt;">&#8221;) shall give written notice to the party required to provide indemnification (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Indemnifying Party</font><font style="font-family:inherit;font-size:11pt;">&#8221;) promptly after such Indemnified Party has actual knowledge of any claim as to which indemnity may be sought, and shall permit the Indemnifying Party to assume the defense of any such claim or any litigation resulting therefrom, provided that counsel for the Indemnifying Party who shall conduct the defense of such claim or litigation, shall be approved by the Indemnified Party (whose approval shall not unreasonably be withheld), and the Indemnified Party may participate in such defense at such party&#8217;s expense, and provided further that the failure of any Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Agreement unless the failure to give such notice is materially prejudicial to an Indemnifying Party&#8217;s ability to defend such action and provided further, that the Indemnifying Party shall not assume the defense for matters as to which there is a conflict of interest or there are separate and different defenses. No Indemnifying Party, in the defense of any such claim or litigation, shall, except with the consent of each Indemnified Party (whose consent shall not be unreasonably withheld), consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect to such claim or litigation. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(d)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Contribution</font><font style="font-family:inherit;font-size:11pt;">. If the indemnification provided for in this Section 10.09 is held by a court of competent jurisdiction to be unavailable to an Indemnified Party with respect to any losses, claims, damages or liabilities referred to herein, the Indemnifying Party, in lieu of indemnifying such Indemnified Party thereunder, shall to the extent permitted by applicable law contribute to the amount paid or payable by such Indemnified Party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party on the one hand and of the Indemnified Party on the other in connection with the untrue statement or omission that resulted in such loss, claim, damage or liability, as well as any other relevant equitable considerations. The relative fault of the Indemnifying Party and of the Indemnified Party shall be determined by a court of law by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the Indemnifying Party or by the Indemnified Party and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission; provided, that in no event shall any contribution by a Purchaser hereunder exceed the proceeds from the offering received by such Purchaser. The amount paid or payable by a party as a result of any loss, claim, damage or liability shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys&#8217; or other reasonable fees or expenses incurred by such party in connection with any proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section 10.9 was available to such party in accordance with its terms. </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">21.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(e)</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Survival</font><font style="font-family:inherit;font-size:11pt;">. The obligations of the Company and the Purchasers under this Section 10.09 shall survive completion of any offering of Registrable Securities in a Registration Statement and the termination of this Agreement. The indemnity and contribution agreements contained in this Section 10.09 are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties and are not in diminution or limitation of other remedies or causes of action that the parties may have under this Agreement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Section 11.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Definitions</font><font style="font-family:inherit;font-size:11pt;">. Unless the context otherwise requires, the terms defined in this Section 11 shall have the meanings specified for all purposes of this Agreement. All accounting terms used in this Agreement, whether or not defined in this Section 11, shall be construed in accordance with GAAP. If the Company has one or more Subsidiaries, such accounting terms shall be determined on a consolidated basis for the Company and each of its Subsidiaries, and the financial statements and other financial information to be furnished by the Company pursuant to this Agreement shall be consolidated and presented with consolidating financial statements of the Company and each of its Subsidiaries. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Affiliate</font><font style="font-family:inherit;font-size:11pt;">&#8221; shall have the meaning ascribed to such term in Rule 12b-2 of the General Rules and Regulations under the Exchange Act. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Business Day</font><font style="font-family:inherit;font-size:11pt;">&#8221; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Effectiveness Date</font><font style="font-family:inherit;font-size:11pt;">&#8221; means the date the Registration Statement pursuant to Section 11 has been declared effective by the Commission. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Exchange Act</font><font style="font-family:inherit;font-size:11pt;">&#8221; means the Securities Exchange Act of 1934, as amended. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">GAAP</font><font style="font-family:inherit;font-size:11pt;">&#8221; means U.S. generally accepted accounting principles consistently applied. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Governmental Entity</font><font style="font-family:inherit;font-size:11pt;">&#8221; means any national, federal, state, municipal, local, territorial, foreign or other government or any department, commission, board, bureau, agency, regulatory authority, self-regulatory organization or instrumentality thereof, or any court, judicial, administrative or arbitral body or public or private tribunal. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">knowledge</font><font style="font-family:inherit;font-size:11pt;">&#8221; by a Person of a particular fact or other matter means the following: (a) if the Person is an individual, that such individual is actually aware or reasonably should be aware, after due inquiry, by virtue of such person&#8217;s office, of such fact or other matter; and (b) if the Person is an entity, that any executive officer of such Person is actually aware or reasonably should be aware, after due inquiry, of such fact or other matter. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Material Adverse Effect</font><font style="font-family:inherit;font-size:11pt;">&#8221; means any (i) adverse effect on the reservation, issuance, delivery or validity of the Shares, as applicable, or the transactions contemplated hereby or on the ability of the Company to perform its obligations under this Agreement, or (ii) material adverse effect on the condition (financial or otherwise), prospects, properties, assets, liabilities, business or operations of the Company or any of its Subsidiaries. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Material Contract</font><font style="font-family:inherit;font-size:11pt;">&#8221; means all written and oral contracts, agreements, deeds, mortgages, leases, subleases, licenses, instruments, notes, commitments, commissions, undertakings, arrangements and understandings: (i) which by their terms involve, or would reasonably be expected to involve, aggregate payments by or to the Company or any Subsidiary during any twelve month period in excess of $1,000,000, (ii) the breach of which by the Company or any Subsidiary would reasonably be expected to have a Material Adverse Effect, or (iii) which are required to be filed as exhibits by the Company with the Commission since January 1, 2017 pursuant to Items 601(b)(1), 601(b)(2), 601(b)(4), 601(b)(9) or 601(b)(10) of Regulation S-K promulgated by the Commission. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Person</font><font style="font-family:inherit;font-size:11pt;">&#8221; means and includes all natural persons, corporations, business trusts, associations, companies, partnerships, joint ventures, limited liability companies and other entities and governments and agencies and political subdivisions. </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">22.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Pro Rata Interest</font><font style="font-family:inherit;font-size:11pt;">&#8221; means the number of Shares purchased by each Purchaser, relative to the total number of Shares being sold hereunder, as reflected on Schedule I attached hereto. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Registration Statement</font><font style="font-family:inherit;font-size:11pt;">&#8221; means a registration statement or registration statements of the Company filed under the Securities Act pursuant to Section 10 hereof. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Reporting Period</font><font style="font-family:inherit;font-size:11pt;">&#8221; means the period commencing on the Closing Date and ending on the earliest of: (i) the date as of which the Purchasers may sell all of the Shares under Rule 144 without volume or manner-of-sale restrictions and without the requirement for the Company to be in compliance with the current public information requirements under Rule 144(c)(1) (or any successor thereto) promulgated under the Securities Act; (ii) the second anniversary of the Closing Date, or (iii) the date on which such Purchaser shall have sold all of the Shares pursuant to a Registration Statement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Required Holders</font><font style="font-family:inherit;font-size:11pt;">&#8221; means: (i) prior to the Closing, the Purchasers agreeing to invest at least 66% of the amount invested by all the Purchasers pursuant to this Agreement and (ii) from and after the Closing, the Purchasers beneficially owning (as determined pursuant to Rule 13d-3 under the Exchange Act) at least 66% of the Shares. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Subsidiary</font><font style="font-family:inherit;font-size:11pt;">&#8221; means any corporation, association trust, limited liability company, partnership, joint venture or other business association or entity, at least 50% of the outstanding voting securities of which are at the time owned or controlled directly or indirectly by the Company. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Trading Day</font><font style="font-family:inherit;font-size:11pt;">&#8221; means any day on which the Common Stock is traded on the Trading Market; provided that &#8220;Trading Day&#8221; shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00:00 p.m., New York time). </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Trading Market</font><font style="font-family:inherit;font-size:11pt;">&#8221; means the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: NYSE Amex Equities, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange or the OTC Markets Group Inc. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Transaction Documents</font><font style="font-family:inherit;font-size:11pt;">&#8221; means this Agreement and all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Section 12.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Miscellaneous</font><font style="font-family:inherit;font-size:11pt;">. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">12.01</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Waivers and Amendments</font><font style="font-family:inherit;font-size:11pt;">. Upon the approval of the Company and the written consent of the Required Holders, the obligations of the Company and the rights of the Purchasers under this Agreement may be waived (either generally or in a particular instance, either retroactively or prospectively and either for a specified period of time or indefinitely). Neither this Agreement, nor any provision hereof, may be changed, waived, discharged or terminated orally or by course of dealing, but only by an instrument in writing executed by the Company and the Required Holders. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">12.02</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Notices</font><font style="font-family:inherit;font-size:11pt;">. All notices, requests, consents, and other communications under this Agreement shall be in writing and shall be deemed delivered: (a) when delivered, if delivered personally, (b) four Business Days after being sent by registered or certified mail, return receipt requested, postage prepaid, (c) one Business Day after being sent via a reputable nationwide overnight courier service guaranteeing next Business Day delivery, or (d) when receipt is acknowledged, in the case of email, in each case to the intended recipient as set forth below, with respect to the Company, and to the addresses set forth on the signature pages hereto, with respect to the Purchasers. </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">If to the Company: </font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Cidara Therapeutics, Inc. </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">23.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6310 Nancy Ridge Dr., Suite 101 </font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">San Diego, California 92121</font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Attn: Matt Onaitis </font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Email: monaitis@cidara.com</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">with copies to: </font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Cooley LLP </font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">4401 Eastgate Mall </font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">San Diego, California 92121 </font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Attn: Charles J. Bair</font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Email: cbair@cooley.com </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">or at such other address as the Company or each Purchaser may specify by written notice to the other parties hereto in accordance with this Section 12.02. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">12.03</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Cumulative Remedies</font><font style="font-family:inherit;font-size:11pt;">. None of the rights, powers or remedies conferred upon the Purchasers on the one hand or the Company on the other hand shall be mutually exclusive, and each such right, power or remedy shall be cumulative and in addition to every other right, power or remedy, whether conferred by this Agreement or now or hereafter available at law, in equity, by statute or otherwise. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">12.04</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Successors and Assigns</font><font style="font-family:inherit;font-size:11pt;">. All the terms and provisions of this Agreement shall be binding upon and inure to the benefit of and be enforceable by the respective parties hereto, the successors and permitted assigns of each Purchaser and the successors of the Company, whether so expressed or not. None of the parties hereto may assign its rights or obligations hereof without the prior written consent of the Company, except that a Purchaser may, without the prior consent of the Company, assign its rights to purchase the Shares hereunder to any of its Affiliates (provided each such Affiliate agrees to be bound by the terms of this Agreement and makes the same representations and warranties set forth in Section 4 hereof). This Agreement shall not inure to the benefit of or be enforceable by any other Person. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">12.05</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Headings</font><font style="font-family:inherit;font-size:11pt;">. The headings of the Sections and paragraphs of this Agreement have been inserted for convenience of reference only and do not constitute a part of this Agreement. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">12.06</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Governing Law; Jurisdiction</font><font style="font-family:inherit;font-size:11pt;">. This Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to its conflict of law principles. Any suit, action or proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated hereby may be brought in any federal or state court located in the City of New York and State of New York, and each of the parties hereby consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding which is brought in any such court has been brought in an inconvenient forum. Process in any such suit, action or proceeding may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">12.07</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Counterparts; Effectiveness</font><font style="font-family:inherit;font-size:11pt;">. This Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, with the same effect as if all parties had signed the same document. All such counterparts (including counterparts delivered by facsimile or other electronic format) shall be deemed an original, shall be construed together and shall constitute one and the same instrument. This Agreement shall become effective when each party hereto shall have received counterparts hereof signed by all of the other parties hereto. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">12.08</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Waiver of Potential Conflicts of Interest</font><font style="font-family:inherit;font-size:11pt;">. Each of the Purchasers acknowledges that Cooley LLP (&#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Cooley</font><font style="font-family:inherit;font-size:11pt;">&#8221;), outside general counsel to the Company, has in the past performed and is or may now or in the future </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">24.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">represent one or more Purchasers or their affiliates in matters unrelated to the transactions contemplated by this Agreement (the &#8220;</font><font style="font-family:inherit;font-size:11pt;font-style:italic;font-weight:bold;">Financing</font><font style="font-family:inherit;font-size:11pt;">&#8221;), including representation of such Purchasers or their affiliates in matters of a similar nature to the Financing.  The applicable rules of professional conduct require that Cooley inform the parties hereunder of this representation and obtain their consent.  Cooley has served as outside general counsel to the Company and has negotiated the terms of the Financing solely on behalf of the Company.  The Company and each Purchaser hereby (a) acknowledge that they have had an opportunity to ask for and have obtained information relevant to such representation, including disclosure of the reasonably foreseeable adverse consequences of such representation; (b) acknowledge that with respect to the Financing, Cooley has represented solely the Company, and not any Purchaser or any stockholder, director or employee of the Company or any Purchaser; and (c) gives its informed consent to Cooley&#8217;s representation of the Company in the Financing. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">12.09</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">California Corporate Securities Law</font><font style="font-family:inherit;font-size:11pt;">.  THE SALE OF THE SHARES HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO SUCH QUALIFICATION OR IN THE ABSENCE OF AN EXEMPTION FROM SUCH QUALIFICATION IS UNLAWFUL.  PRIOR TO ACCEPTANCE OF SUCH CONSIDERATION BY THE COMPANY, THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON SUCH QUALIFICATION BEING OBTAINED OR AN EXEMPTION FROM SUCH QUALIFICATION BEING AVAILABLE.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">12.10</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Entire Agreement</font><font style="font-family:inherit;font-size:11pt;">. This Agreement contains the entire agreement among the parties hereto with respect to the subject matter hereof and thereof and, except as set forth below, this agreement supersedes and replaces all other prior agreements, written or oral, among the parties hereto with respect to the subject matter hereof and thereof. Notwithstanding the foregoing, this Agreement shall not supersede any confidentiality or other non-disclosure agreements that may be in place between the Company and any Purchaser. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">12.11</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Severability</font><font style="font-family:inherit;font-size:11pt;">. If any provision of this Agreement shall be found by any court of competent jurisdiction to be invalid or unenforceable, the parties hereby waive such provision to the extent that it is found to be invalid or unenforceable. Such provision shall, to the maximum extent allowable by law, be modified by such court so that it becomes enforceable, and, as modified, shall be enforced as any other provision hereof, all the other provisions hereof continuing in full force and effect. </font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">* * * </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:312px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">25.&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><a name="s7A95BCEA8C69EA6DC71B35F9993CA6A5"></a></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed as of the Effective Date. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:42.857142857142854%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:10%;"></td><td style="width:4%;"></td><td style="width:86%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">THE COMPANY:</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">CIDARA THERAPEUTICS, INC.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;/s/ Jeffrey Stein, Ph.D.</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:  Jeffrey Stein, Ph.D.</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title:  President and Chief Executive Officer</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed as of the Effective Date. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:43.84920634920635%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:4%;"></td><td style="width:76%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">PURCHASERS:</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;Biotech Target N.V.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;/s/ Michael Hutter</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;Michael Hutter</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;CFO BB Biotech AG</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed as of the Effective Date. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:43.84920634920635%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:4%;"></td><td style="width:76%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">PURCHASERS:</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;Broadfin Healthcare Master Fund, Ltd.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;/s/ Kevin Kotler</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;Kevin Kotler</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed as of the Effective Date. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:43.84920634920635%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:4%;"></td><td style="width:76%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">PURCHASERS:</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;DAFNA LifeScience LP</font></div><div style="padding-left:5px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">DAFNA LifeScience Select LP</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">/s/ Nathan Fischel</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Nathan Fischel</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">CEO</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed as of the Effective Date. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:43.84920634920635%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:4%;"></td><td style="width:76%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">PURCHASERS:</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">&#160;Biomedical Value Fund, L.P.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">/s/ David Kroin</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">David Kroin</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Managing Director of Great Point</font></div><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Partners, LLC (the Inv Manager)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed as of the Effective Date. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:43.84920634920635%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:4%;"></td><td style="width:76%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">PURCHASERS:</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;Biomedical Offshore Value Fund, Ltd.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">/s/ David Kroin</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">David Kroin</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Managing Director of Great Point</font></div><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Partners, LLC (the Inv Manager)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed as of the Effective Date. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:43.84920634920635%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:4%;"></td><td style="width:76%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">PURCHASERS:</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;GEF-SMA, L.P.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">/s/ David Kroin</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">David Kroin</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Managing Director of Great Point</font></div><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Partners, LLC (the Inv Manager)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed as of the Effective Date. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:43.84920634920635%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:4%;"></td><td style="width:76%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">PURCHASERS:</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;Class D Series of GEF-PS, L.P.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">/s/ David Kroin</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">David Kroin</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Managing Director of Great Point</font></div><div style="font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Partners, LLC (the Inv Manager)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed as of the Effective Date. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:43.84920634920635%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:4%;"></td><td style="width:76%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">PURCHASERS:</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;Lawrence Lytton</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;/s/ Lawrence Lytton</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;Lawrence Lytton</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed as of the Effective Date. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:43.84920634920635%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:4%;"></td><td style="width:76%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">PURCHASERS:</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On Behalf of: Prosight Fund, LP</font></div><div style="text-align:left;text-indent:82px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Prosight Plus Fund, LP</font></div><div style="text-align:left;padding-left:84px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Undiscovered Value Master Fund SPC - April, 2014 Segregated</font></div><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Prosight Capital/Prosight Fund/Prosight Plus Fund/Undiscovered Value Fund</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">/s/ Lawrence Hawkins</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Lawrence Hawkins</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Managing Member</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed as of the Effective Date. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:43.84920634920635%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:4%;"></td><td style="width:76%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">PURCHASERS:</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;Pura Vida Investments, LLC</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">/s/ David DeMartino</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">David DeMartino</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Analyst</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed as of the Effective Date. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:43.84920634920635%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:4%;"></td><td style="width:76%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">PURCHASERS:</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;Sphera Global Healthcare Master Fund</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;/s/ Doran Breen</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;Doran Breen</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed as of the Effective Date. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:43.84920634920635%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:4%;"></td><td style="width:76%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">PURCHASERS:</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Hfr He Sphera Global Healthcare Master Trust</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;/s/ Doran Breen</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;Doran Breen</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;Director, Trading Advisor</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed as of the Effective Date. </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:right;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:43.84920634920635%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:4%;"></td><td style="width:76%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">PURCHASERS:</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">CVI Investments, Inc.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">/s/ Martin Kobinger</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Name:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Martin Kobinger</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Title:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Investment Manager</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">SCHEDULE I</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:47%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:36%;"></td><td style="width:1%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:16px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">SCHEDULE OF PURCHASERS</font></div><div style="padding-top:16px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Name and Address</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Shares</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Aggregate <br>Purchase Price</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Biotech Target N.V.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">900,000</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;text-indent:2px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$5,400,000.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Biomedical Value Fund, L.P.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">211,762</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;text-indent:2px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$1,270,572.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Biomedical Offshore Value Fund Ltd.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">302,835</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$1,817,010.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">GEF-SMA, L.P.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">225,830</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$1,354,980.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Class D Series of GEF-PS, L.P.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">59,573</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$357,438.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Prosight Fund, LP</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">316,081</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$1,896,486.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Prosight Plus Fund, LP</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">287,962</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$1,727,772.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">UNDISCOVERED VALUE MASTER FUND SPC &#8211; APRIL, 2014 SEGREGATED</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">45,957</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$275,742.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Pura Vida Investments, LLC</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">275,000</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;text-indent:2px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$1,650,000.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">SPHERA GLOBAL HEALTHCARE MASTER FUND</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">203,238</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;text-indent:2px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$1,219,428.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">HFR HE SPHERA GLOBAL HEALTHCARE MASTER TRUST</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">6,762</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$40,572.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">LAWRENCE LYTTON</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">200,000</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$1,200,000.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">BROADFIN HEALTHCARE MASTER FUND, LTD.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">150,000</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;text-indent:2px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$900,000.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">DAFNA LIFESCIENCE LP</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">59,000</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;text-indent:2px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$354,000.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">DAFNA LIFESCIENCE SELECT LP</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">41,000</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$246,000.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">CVI INVESTMENTS, INC.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">75,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$450,000.00</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Total:</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:10px;"><div style="padding-bottom:16px;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">3,360,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:16px;text-align:right;padding-left:38px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">$20,160,000.00</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">EXHIBIT A</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">PLAN OF DISTRIBUTION</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">We are registering the shares of common stock issued to the selling stockholders to permit the resale of such shares of common stock by such holders from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale by the selling stockholders of the shares of common stock. We will bear all fees and expenses incident to our obligation to register such shares of common stock.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Each selling stockholder, which may include donees, pledgees, transferees or other successors-in-interest selling shares of common stock or interests in shares of common stock received after the date of this prospectus from a selling stockholder as a gift, pledge, partnership distribution or other transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of its shares of common stock or interests in shares of common stock on any stock exchange, market or trading facility on which the shares are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at privately negotiated prices. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">A selling stockholder may use any one or more of the following methods when disposing of shares or interests therein: </font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block as principal to facilitate the transaction; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">purchases by a broker-dealer as principal and resale by the broker-dealer for its own account; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">an exchange distribution in accordance with the rules of the applicable exchange; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">privately negotiated transactions; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">to the extent permitted by law, short sales effected after the date the registration statement of which this prospectus is a part is declared effective by the SEC; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">through agreements between broker-dealers and the selling stockholders to sell a specified number of such shares at a stipulated price per share; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">a combination of any such methods of sale; and </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:24px;"><font style="font-family:inherit;font-size:11pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">any other method permitted by applicable law.</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The selling stockholders may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock, from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b) or other applicable provision of the Securities Act amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer the shares of common stock in other circumstances, in which case the pledgees, transferees or other successors in interest will be the selling beneficial owners for purposes of this prospectus. </font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">In connection with the sale of our common stock or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they assume. The selling stockholders may also sell shares of our common stock short and deliver these securities to close out their short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into options or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to each such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). </font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The aggregate proceeds to the selling stockholders from the sale of the common stock offered by them will be the purchase price of the common stock less discounts or commissions, if any. Each of the selling stockholders reserves the right to accept and, together with its agents from time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly or through agents. We will not receive any of the proceeds from this offering. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The selling stockholders also may resell all or a portion of the shares in open market transactions, rather than under this prospectus, in reliance upon Rule 144 under the Securities Act of 1933, provided that they meet the criteria and conform to the requirements of that rule. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The selling stockholders and any underwriters, broker-dealers or agents that participate in the sale of the common stock or interests therein may be &#8220;underwriters&#8221; within the meaning of Section 2(11) of the Securities Act. Any discounts, commissions, concessions or profit they earn on any resale of the shares may be underwriting discounts and commissions under the Securities Act. Selling stockholders who are &#8220;underwriters&#8221; within the meaning of Section 2(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities Act. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">To the extent required, the shares of our common stock to be sold, the names of the selling stockholders, the respective purchase prices and public offering prices, the names of any agents, dealer or underwriter, and any applicable commissions or discounts with respect to a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">If underwriters are used in the sale, the shares of common stock will be acquired by the underwriters for their own account and may be resold from time to time in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at the time of sale. In connection with any such underwritten sale of shares of common stock, underwriters may receive compensation from the selling stockholders, for whom they may act as agents, in the form of discounts, concessions or commissions. If the selling stockholders use an underwriter or underwriters to effectuate the sale of shares of common stock, we and/or they will execute an underwriting agreement with those underwriters at the time of sale of those shares of common stock. To the extent required by law, the names of the underwriters will be set forth in a prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes the prospectus supplement and the accompanying prospectus used by the underwriters to sell those securities. The obligations of the underwriters to purchase those shares of common stock will be subject to certain conditions precedent, and unless otherwise specified in a prospectus supplement, the underwriters will be obligated to purchase all the shares of common stock offered by such prospectus supplement if any of such shares of common stock are purchased. Any public offering price and any discounts or concessions allowed or re-allowed or paid to dealers may be changed from time to time.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">We have advised the selling stockholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares in the market and to the activities of the selling stockholders and their affiliates. The selling stockholders may indemnify any broker-dealer that participates in transactions involving the sale of the shares against certain liabilities, including liabilities arising under the Securities Act. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">We are required to pay certain fees and expenses incurred by us incident to the registration of the shares of common stock of the selling stockholders. We have agreed to indemnify the selling stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act, and the selling stockholders may be entitled to contribution. We may be indemnified by the selling stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act that may arise from any written information furnished to us by the selling stockholders specifically for use in this prospectus, or we may be entitled to contribution.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">We have agreed with the selling stockholders to keep the registration statement of which this prospectus constitutes a part effective until the earlier of (1) such time as all of the shares covered by this prospectus have been disposed of pursuant to and in accordance with the registration statement or (2) the date on which all of the shares may be sold without restriction pursuant to Rule 144 of the Securities Act. </font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Once sold under the registration statement of which this prospectus forms a part, the shares of common stock will be freely tradable in the hands of persons other than our affiliates.</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">* * * </font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:left;text-indent:336px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex991-pressrelease2017x10x.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s3BC766B8A9126DFC5F1435582B260CB6"></a></div><div><div style="line-height:120%;text-align:right;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Exhibit 99.1</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font><img src="cdtxlogosec.jpg" alt="cdtxlogosec.jpg" style="height:98px;width:240px;"></div><div style="line-height:120%;text-align:left;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;"><br></font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SAN DIEGO, October 19, 2017 -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the pricing of a private placement of 3,360,000 shares of its common stock at a price of $6.00 per share. The syndicate of investors in the private placement was comprised of new and existing investors, including Great Point Partners, LLC, BB Biotech AG, Prosight Capital, Broadfin Capital, LLC and certain other institutional investors. The gross proceeds to Cidara from the private placement are expected to be approximately $20 million. The private placement is expected to close on or about October 24, 2017, subject to the satisfaction of customary closing conditions.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cantor Fitzgerald &amp; Co. acted as sole placement agent for the offering. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The securities described above have not been registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or any state or other jurisdiction&#8217;s securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state or other jurisdictions&#8217; securities laws. The Company has agreed to file a registration statement with the Securities and Exchange Commission registering the resale of the shares of common stock to be issued and sold in the private placement. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:24px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">About Cidara Therapeutics </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cidara is a clinical-stage biotechnology company focused on developing new anti-infectives that have the potential to transform the standard of care and save or improve patients&#8217; lives. The company is currently advancing its novel echinocandin antifungal, CD101 IV, through Phase 2 and developing CD201, its bispecific antibiotic immunotherapy, for the treatment of multi-drug resistant Gram-negative bacterial infections. CD101 IV has improved pharmacokinetics compared to existing echinocandins and has the potential for expanded utility across patient settings. CD101 IV is the only once-weekly product candidate in development for the treatment and prevention of life-threatening invasive fungal infections. CD201 is the first drug candidate selected from Cidara&#8217;s novel Cloudbreak&#8482; platform, the first immunotherapy discovery platform designed specifically to create compounds that direct a patient&#8217;s immune cells to attack and eliminate bacterial, fungal or viral pathogens. Cidara is headquartered in San Diego, California. For more information, please visit www.cidara.com.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Forward Looking Statements</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding the completion, timing and size of the private placement described above. Risks that contribute to the uncertain nature of the forward-looking statements include risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the private placement, as well as risks and uncertainties associated with Cidara&#8217;s business and finances in general. These and other risks and uncertainties are described more fully in Cidara&#8217;s Form 10-Q most recently filed with the United States Securities and Exchange Commission. There can be no assurance that Cidara will be able to complete the private placement on the anticipated terms or at all. All forward-looking statements contained in this press release speak only as of the date on which </font></div><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">they were made. Cidara undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investor Contact: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Robert H. Uhl</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Westwicke Partners, LLC</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Managing Director</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(858) 356-5932</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">robert.uhl@westwicke.com</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Media Contact: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Christy Curran</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sam Brown Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(615) 414-8668</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">christycurran@sambrown.com</font></div><div><br></div><div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>cdtxlogosec.jpg
<TEXT>
begin 644 cdtxlogosec.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!817AI9@  34T *@    @ ! ,"  (
M   2    /E$0  $    ! 0   %$1  0    !   N(U$2  0    !   N(P
M  !S4D="($E%0S8Q.38V+3(N,0#_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#Y;_X*I?MFW'[+'P6ATS0+CR/&'BXR6]E*I^:P@4#S;@>C#<JI_M-NYV$
M5^.5Q<27<\DLKO)+(Q=W<[F<GDDGN37U)_P6.^(-QXS_ &W]:T^21FMO"]C:
M:;;KGY0&A6X?CUWSL/P%?+%?@/&.:5,7F4X-^[3;BEZ:-_-_A;L?TYP%DU/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^,O_  5Z\&W'A3]N
MSQ1<2JRPZ[;V>HVY(^\AMTB8_P#?R*0?A7S+7ZS?\%COV0;OXW_"BS\<>'[5
MKKQ!X+C?[5!$NZ2[L&^9\#J6B8%P/[K2=3@5^3-?S[Q=EL\)F=3F7NS;DGWO
MJ_N=T?U#P-FU/'9/2Y7[U-*$EV<59?>K,****^9/KPKMOV;?!L_Q"_:#\$:)
M;HSR:EKEG!P/NJ9DW-]%7)/L*XFOT!_X(H_L@W>K>,)OBUK=JT.FZ8DEGH(D
M7'VJ=@4EG7_91"R ]"SMCE#7KY#ET\=CJ=""ZIOR2W?]==#P^),VIY=EU7$U
M'K9I><GHE]_X79^F=%%%?TB?R6%%%>6_M9?M;^%OV0/ANVO>(I6FNK@M%INF
M0L/M&I2@9VKG[JC(+.>%!'4E5..(Q%.A3=:L^6,=6V=&%PM;$U8T*$7*4G9)
M=3U)FVKD\ <DGM7FOC/]LGX4?#Z\:VU?XB>$+6ZC.'@&IQ22QG_:1"6'XBOR
M%_:D_P""@WQ'_:KU*XCU;5YM)\/2,1%HFG2-#:*G828YF;W<D9S@*.*\/K\T
MS#Q(49N.#I77>3M?Y+_/Y'ZYE?A/*4%/'UN5_P L5>W_ &\_T7S9^]'A#]L_
MX3>/+Q;;2OB+X/N;F0X2%M3BBDD/HJN03^ KTM)%E165@RL,@@Y!%?SF5[-^
MS)^WE\2/V5M4@_L'6Y[S1$8>;HM^[3V,J]PJDYB)_O1E3P,Y'%+ >)"<U'&4
MK+O%[?)_YE9EX3.,'+ 5KOM);_-?Y?-'[G45Y#^QW^V7X7_;)^'AU;0V:RU2
MQVQZII,SAI["0CCGC?&V#M<  X((!!4>O5^EX;$TL125:C+FC+5-'Y#C,'6P
MM:6'Q$7&<79I_P!?=W"BBBMSG"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ^6_^"QOAZ;6_P!A?79X59ETO4+*[D _
MN^<L7Z&05^-]?T&_&GX7V?QK^$OB+PGJ!VVOB#3YK)GQDPEU(60#U5L,/=17
MX&?$7P!JGPJ\=ZMX;UJW:TU;1;J2TN8CV=#C(/=3U!Z$$'O7X[XC8*<<73Q7
MV91M\TV_R?X,_>/"C,(3P57!-^]&7-\FDOP:U]48M%%%?G)^L!1110 5^O7_
M  1/\.S:)^Q6+J165-8UZ\O(B?XE"Q0Y'_ H6'X5^2_A#PGJ'CSQ5INB:3:R
M7NJ:M<QVEK!&/FED=@JJ/J37[W?LZ?!ZW^ 'P-\+^#;5ED70+".WED486:;[
MTL@'^W(SM_P*OT3PZP<YXV>)^S&-OFVOT3_ _*_%;,(4\OIX2_O3E>WE%/\
M5K\3M****_9#\#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI>77[GK^!OT445QGI!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<8_ZSY3_ -!$?O/LZBOD_1/^"U?[/^JNJS^(]8TT-U-SHMRP7_OVKUZ!X/\
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M;U*QTC2K%/,N;R\G6&"!<@99V("C) Y/>FDV[(4I**N]C0HKRO\ X;F^"_\
MT5?X=_\ A06O_P 71_PW-\%_^BK_  [_ /"@M?\ XNM_JE?^1_<SD_M#"_\
M/V/_ ($O\SU2BO+[7]MSX.7UU'##\5/A[+-,P1$77[4L[$X  W]2:]0K.I2G
M#XTUZJQM1Q%*K_"DI6[-/\@HHHK,V"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P U^*UZ,]_HHHKY4^_"BBB@ J&_OX-*L9KJZFAMK:W0R2RRN$CB0#)9F/
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M^/K#]HWP3X:\(^+/$.A0Z]K=K:7$-G>.D#1/*OFL\6=C )N/*GI7[Z5^+?\
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M_L4[3_TINZ^FX3_W_P"3/B/$#_D4O_%']3XEHHHK]./PH_I(^'G_ "(&A_\
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MF&TDG]_3Y;!1117.=@4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4V6588V=V544%F9C@ #N:=7S-_P5O^/4WP&_8H\1/93&WU3Q4Z>'[1
MU.&3SPQF([Y\A)0".A(-=&%P\J]:-&.\FD<F/QD,+AIXF>T4W]W3YGYJ?\%0
MOVY;K]K_ ..%Q::7=2?\()X7F>VT>!6_=W;#Y7O&'=GQ\N?NI@8!+9^8Z**_
M9,+AH8>E&C36B/YIQV.JXNO+$UW>4G?_ ('HMD%%%%=!R!1110 5]T_\$7_V
MZKCX/_%&W^&'B*\9O"?BRXV:8TK_ "Z9?M]T+Z),<*1TWE#QER?A:I+6ZDL;
MJ.:&22&:%@\<B-M9&!R"".A![UR8[!PQ5"5"IL_P?1GH95F57 8J&*H[Q>W=
M=4_7_@G]+E%>7_L7_'$_M'_LN>"O&4C*]YJVG*M\5X'VJ(F&?CL#+&Y ]"*]
M0K\:K4Y4YNG+=-I_(_I;#UX5J4:U/:237HU=!6;XR:1?"&JF'/G"SF*8Z[MA
MQ6E0RAU((R#P0>]1%V=S22NK'\S]%=1\;OA[-\)OC)XJ\+S(R2>']7NM/P>X
MBE9 ?H0 0>X-<O7[C&2E%26S/Y8J4Y0DX2W3M]P44451 4444 %%%% !112H
MC2NJJI9F.  ,DF@#]\_^"<!D/["OPO\ -SN_L*'&?[O.W],5[97&?LY_#Y_A
M/^S_ ."?#,B[9M T*RL)A_TTC@17/XL"?QKLZ_$\5-3KSFMFV_Q/Z@R^G*GA
M:=.6ZC%?<D%%%%<YV'XM?\%:-!ET/]O;QLTBL([\65U$3_$K6<(/Y,K#\*^<
M*_1+_@NU\!9EU3PI\2;.%FMWB.A:DRC_ %; M+;L?]X-*I)_NH.XK\[:_G;B
MC"2P^:5H2ZR<EZ2U_6Q_57!N.ABLFP\X?9BHOUC[OZ7^84445X!],%%%% !7
M3_!/0)?%7QE\(Z7 I:;4M:L[6,#J6>=%'\ZYBOJK_@C[\!IOBY^UO8:W-"S:
M/X&B.JW#D?*9R"ENF?[V\F0>T+5Z&5826*QE+#PWE)+Y=7\EJ>9G6.A@\!6Q
M,]HQ;^=M%\W9'[%4445_3!_(04444 %>"_\ !2_]H1OV;?V.?%FM6LYM]8U.
M(:-I;*=K+<7&4WJ?[R1^9(/>.O>J_+__ (.#OB^USXG\ ^ X92([.VFUV\C!
MX9I&,,!/NHCG_P"^Z]7),(L1C84WM>[]%K^.QX'%&8/!Y95K1^*UEZO3\-_D
M?F_1117Z^?SD?3'_  2B_96C_:A_:MTU-3MA<>&?":#6=45US'/L8"& ]COD
M*Y!ZHDE?N17Q7_P0O^""_#O]DFX\530[=0\=ZC)<!R,-]EMRT,2G_@8G8>T@
MK[4K\KXEQKKXV45M#1?K^/Y'[YP3E:PF61FU[U3WGZ/X5]VOJV%%%%?/GV 4
M444 %%%% !1110 4444 %%%% 'X0?\%3_P#E(!\2O^O^'_TFAKY^KZ!_X*G_
M /*0#XE?]?\ #_Z30U\_5^T9;_NE+_#'\D?S+G/_ ",*_P#CE_Z4SU+]AW_D
M\[X3_P#8W:7_ .E<5?T'5_/C^P[_ ,GG?"?_ +&[2_\ TKBK^@ZOB>,OX]/T
M?YGZAX:_[K6_Q+\@HHHKXT_2@K\6_P#@M_\ \GXZE_V!['_T U^TE?BW_P %
MO_\ D_'4O^P/8_\ H!KZCA'_ 'Y_X7^:/@_$3_D5+_&OR9\AU+8_\?L/^^O\
MZBJ6Q_X_8?\ ?7^=?IA^(1W/Z6Z***_"S^JPHHHH **** "BBB@#P'_@HY^Q
MO:?MD?L]7VF0PQ?\)7HBO?Z!<G 99P/F@)_N2@;#V!V-SM%?A#>6<VGW<MO<
M1R0SP.8Y(W4JT; X((/((/&*_I<K\4_^"S/[.T?P._;"OM6L;?R='\>0?VU"
M%7")<%BMR@]S(/,/_785]QPCF#4G@YO3=?JOU^\_+?$7)XN$<RIK5>[+TZ/Y
M;?-=CY+K<^&/Q#U+X2_$30_%&CS>3JF@7T5_;-VWQN& /JIQ@CN"16'17W4H
MJ2Y7L?D\)RC)2CHT?T@?"GXC:?\ %[X9Z!XJTMMVG^(=/AU"#G)59$#[3_M#
M.".Q!KH*^,O^"&GQ@;XA?L;MH%Q+YEUX)U6:Q12<L+>7$\9/MNDE4>R5]FU^
M,X_#/#XB='^5O[NGX']-93CEC,%2Q/\ -%-^O7\;A1117&>@%%%% '&?M$?&
M&T^ 'P-\5>,[W8T/AW3I;M$8X$TH&(H_J\A1![M7\[WB#7KOQ3KU]JFH3/<W
MVI7$EU<S/]Z61V+,Q]RQ)_&OU0_X+[?'[_A&?A'X9^'5G-MNO$]V=3U!5/(M
M;<XC5AZ/,P8>\!K\HZ_2.$<'[/"NN]YO\%_P;GXGXB9E[;'1PL=J:U]9:O\
M"WXA7Z9?\&_7P&VQ^-/B5=P_>*^']-<CM\LUR1_Y+@$>C"OS-52[  9)X '>
MOZ!OV%_@1_PS=^RCX+\)R0^3J%I8+<:B,?-]KF)EF!]=KN5!]%%:\5XSV6#]
MDMYNWR6K_1?,Q\/\N^L9C[>2TIJ_S>B_5_(S?^"B'P&_X:,_8^\:>'H8?.U.
M&S.I:: ,M]IM_P!ZBK[N%:/Z2&OP+K^F"OP)_P""AGP&_P"&<OVO_&GAV&'R
M=,DO3J.F@#"_9;C]ZBK[)N,?UC->9P;C/CPS_P 2_)_H>YXDY=_"QT5_=?YK
M]?P/%:_63_@@?\?O^$M^"?B+X>WDVZZ\)7GVZQ5CUM+DDLJCT297)_Z["OR;
MKZ&_X):_'[_AGO\ ;1\*7UQ-Y.DZ_(=!U$DX7RK@A49CV"S")R?1#7T6>X/Z
MS@IP6ZU7JO\ -71\7PIF7U+,Z=1_#)\K]'I^#L_D?NU1117Y&?T4%%%% !11
M10 5^//_  7L_P"3TM)_[%.T_P#2F[K]AJ_'G_@O9_R>EI/_ &*=I_Z4W=?3
M<)_[_P#)GQ'B!_R*7_BC^I\2T445^G'X4?TD?#S_ )$#0_\ L'V__HM:V*Q_
MAY_R(&A_]@^W_P#1:UL5^&S^)G]44O@7H%%%%2:!1110 5\\?\%5/A1#\6OV
M$_'D+1![K0K0:[;/C)B:U/F.1]8A*OT8U]#UQ_[0VG1ZQ\ ?'%I* T=UX?OX
M7![AK:0'^==.#J.G7A471I_B<694(UL)5HRVE%K[T?SGT445^UG\P'Z$_P#!
MO=XP>R^,WQ!\/[CY>I:+!J!7L3;S^6#_ .3)_.OU7K\>?^"",[1?MHZPJYQ)
MX3NU;Z?:;0_S K]AJ_+N*HI9A)]TORM^A^\< U'+*(I])27XW_4****^</M
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M.ZC/I\IQ@2&-RH<>S !AZ@BN;K[E_P""[_P&_P"$ _:8TOQK:P[+'QU8#SV
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MU\_5] _\%3_^4@'Q*_Z_X?\ TFAKY^K]HRW_ '2E_AC^2/YESG_D85_\<O\
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M])H:^?J^@?\ @J?_ ,I /B5_U_P_^DT-?/U?M&6_[I2_PQ_)'\RYS_R,*_\
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MI+F*<8[XC=B!Z@5_0;!.ES"DD;+)'(H964Y5@>00:_FAK]T?^"4GQ^_X7_\
ML5^%[BXF\[5O#*G0-0R<MOMPHC8]R6@:%B3U):OG^,<'>,,5'IH_S7Z_>?8>
M&^96G4P,NOO+U6C_  M]Q]'T445\$?K04444 %?CS_P7L_Y/2TG_ +%.T_\
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M!P2:^=QW$V#H*U-\\NRV^_;[KGVF5<"YEBVI5E[./>6_RCO]]CXF_P""=_\
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M;>*=2UK4IFN=1U:ZEO;J5NLLLCEW8_5B36?117[,DDK(_FB4FW=GWE_P04^
MW_"9_M Z]X\NH=UGX,L/LUHQ'_+W=!DR#WVPK,#Z>8M?K=7S-_P2/^ W_"B_
MV)O#9N(?)U3Q;N\07F1AOWX7R1Z\0+%QV):OIFOR3/\ &?6,;.2V6B^7_!NS
M^A^$<N^IY73@U[TES/U>OX*R^04445XQ](%-FA6XA:.15DCD!5E89# ]013J
M* /Y[?VS/@8_[-W[3_C/P?Y;1VFEZB[6.?XK23$L!SW_ '3H#[@UYC7Z0_\
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M<)=VES"</#(A!5A^(Z'@]#Q7[P?L$?MD:7^VE\"K/Q!#Y-KX@T_;::[8(?\
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M-?DSY#J6Q_X_8?\ ?7^=15+8_P#'[#_OK_.OTP_$([G]+=%%%?A9_584444
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M%/!1>LGS/T6WWO\ (J5J>"O!^H_$/QCI6@Z1;M>:KK5W%8V<"G!EFD<(BY/
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MMBFU%-)6:5WN]T]M/O/Q/_X<K?M ?]"UI/\ X.K7_P"+H_X<K?M ?]"UI/\
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MF"BOQP_8C_X+*^,/V<M/L_#?C2WN/&WA&V B@=I<:EIT8X"QR-Q*@'1),$<
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M?$C+Y<U+'16EN5_FOS9^U>$^:1Y:V72>M^=>>RE]UE^)Y/1117Y:?LP4444
M%%%% !1110!]%?\ !*?X:R?$G]N'PA^[+VN@M-K-RP'^K6&,^6?^_P T0_&O
MVJKX7_X(B?LU2^ _A3JWQ$U.W,=]XO86NFAUPR643'<X[XDE_,1(1P:^Z*_=
M^!\OEA<L4IK6H^;Y.R7X*_S/YK\1LTCC,XE"F[QII0^:NW^+M\@HHHK[$^#"
MLOQMX)TGXD>$[_0M>T^VU32-4B,%U:W";HY4/8^XX((Y! (((!K4HJ914DXR
M5TRHRE&2E%V:V9^4?[:/_!'CQ1\)[^[UWX;0W?BSPRQ,ITY?GU/3Q_="C_7H
M.Q3Y_53@L?BR]LIM-NY+>XAEM[B%BDD<B%7C8<$$'D$>AK^B^O/_ (P?LK_#
MKX^ MXO\'Z'K5P5V_:I(/+N@/03)MD ]@U?G.<>'M&M-U<#/D;^R]5\GNOQ/
MUC(O%*O0@J.90]HE]I:2^:>C];KSN?@717[ Z]_P1:^".L7#26]KXFTI6.1'
M:ZJ65?\ OZKG]:L^%?\ @C5\#?#ERLEUI.N:YM.=E]JL@4_40^77S*\/<TYK
M7AZW?^5SZY^*63<O-:=^W*K_ /I5OQ/R%\+>$]4\<:[;Z7HNFWVK:E=MLAM;
M.!III3Z*J@DU^@_[#/\ P1KN(M0L_%/Q>BB6.$B:V\-(XD\P]0;IU.,=_*4G
M/&XCE#]Y_"[X&^#O@EIK6GA+PSHOA^%QB0V5JL<DW^^X&YS[L2:ZJOK<EX!P
M^&FJV,E[22Z6M'Y]7^"\CX?B#Q-Q6+@Z& C[*+W=[R?ITC\KOLT1VMK'8VT<
M,,<<,,*A(XT4*J*!@  <  <8%2445^@GY>%%%% !1110 4444 %%%% !1110
M 5Y5^UW^R#X3_;*^%TOAWQ+ 8KB'=+INIPJ/M.F3$??0GJIP R'A@.Q"L/5:
M*THUITIJI3=FMF8XC#TZ]-T:T>:,M&F?S\_M;_L7^-OV-O'3:3XHL6DT^X=O
M[.U>W4M9ZB@[HW\+@=8VPR^X()\EK^D7XB?#?0?BUX1O-!\3:38ZYH]\NV>T
MNXA)&_H>>C#J&&"#R"#7YU?M6?\ !!4R7%SJWPBUJ-(V)?\ L'6)3\G^S#<X
M.?0+*/K)7Z%E?%5&JE3Q?NR[]'_E^1^/9]P#B*$G5R_WX?R_:7^?Y^3W/S/H
MKN_C-^S'\0/V>M1:V\9^$=;T##;5GN+<FVE/^Q,N8W_X"QKA*^KIU(SCS0::
M[K4_/JM&I2ER58N+71JS^YG8>!?VAO'WPPB2/PWXV\6:#%'TCT_5I[>/Z;48
M#'MBO0]-_P""EWQXTJ,+%\3O$K ?\]I$F/YNI->&45E4PM";O."?JDSHHYAB
MJ2M2J2BO*37Y,]YNO^"GOQ\O$VO\3=?4?["PQG\U05SFO?MT?&;Q*K+=_%+Q
MZRMU2+6[B%3]0C 5Y314QP.'C\-.*^2*GFF-GI.M)^LG_F;'B;XA^(/&CEM8
MUS6-68G)-[>R3D_]]$UCT45TQBDK(XY2E)WD[GV'_P $-O%O_".?MU6UGNV_
MV]H=[8X_O;0EQC_R!G\*_9VOP[_X)6^ /&5K^V?\/O$NF^%_$5YH]G?M'=ZA
M!ITSVMO#-#)"[O*%VJH$AR2:_<2OS;BZ,?KBE'K%??=G[;X=RE_9LH23TF[>
MC2_6X4445\J?>GX0?\%3_P#E(!\2O^O^'_TFAKY^KZ(_X*EZ;<S_ +?GQ*9+
M>9U:_BP5C)!_T:&OG_\ LB[_ .?6X_[]'_"OV?+G_LE+_#'\D?S-G,7_ &A7
M_P <O_2F>E?L._\ )YWPG_[&[2__ $KBK^@ZOY^?V(-+NH_VR_A2S6]PJKXN
MTLDF,X ^UQU_0-7Q7&7\>GZ/\S]/\-?]UK?XE^04445\:?I05^+?_!;_ /Y/
MQU+_ + ]C_Z :_:2OR9_X+'?LL_$CXB?M=7WB3P]X&\4:]H<FEVD2W>FZ=)=
MIN1"&!\L$C'N*^EX5J0AC;S:7NO?U1\1Q_1J5,L4:<6WS+97Z,^!:*U?$W@7
M7/!4_E:SHVJZ3)G&R]M)+=L_1@*RJ_3E)-71^&2BXNTEJ%2V=]-I\PDMYI8)
M!T:-RK#\145%,DW[?XJ^*+1-L7B37XU]$U"51_Z%5/5?&NLZ]&5OM6U.\5NH
MGNGD!_[Z)K,HJ53BG=(T=6;5FV%%%%49A17I'PD_8^^*'QUEB_X17P+XDU:&
M;[MT+-H;3\9Y-L0_%J^P?V??^"!/BKQ%+!>?$GQ-8^';,X9]/TG%Y>L.ZM*0
M(HS[KYHKS\5FN$PR_>S2?;=_<M3V,OR#,,:_]GI-KO:R^]V1\">&_#6H^,==
MM=+TFPO-4U*^D$5O:VL+333N>BJB@EC[ 5^EG_!/W_@BI_9-W8^,/C);PS31
ME9[/PN&$B*>H:[8<-Z^4I(Z;B>4K[2_9L_8M^&_[)VE>3X,\.VUG>2)LGU.X
M_P!(O[D=]TS<@'KM7:N?X17JE?$YKQ54K)TL*N6/?J_\OS/T_(. :.&DJ^/:
MG);17PKU[_@O)C8($M8$CC18XXU"HBC"J!P !V IU%%?(GZ*%>._M\?'W_AF
MK]DSQEXHBF\G4H[(V6F$'#?:Y_W41'KL+;R/1#7L5?F/_P %^_C;<:MKG@[X
M;:?YTD-DC:]J0C4LID?=%;J<=U43''I(IKU,FP?UG&0I/:]WZ+7\=CPN),R^
MI9=5KQ^*UEZO1?=O\C\UR=QR:*L?V1=_\^MQ_P!^C_A1_9%W_P ^MQ_WZ/\
MA7[!='\Y<K/NS_@@G\!/^$R^/NO>/KN'=9^#;'[+9LP_Y>[D,N0?]F%90?3S
M5K];*^:_^"3?P#/P$_8I\,QW,'DZMXI#>(+X%<,#.%\I3W&(%B!!Z'=7TI7Y
M'GV,^L8V<ELM%Z+_ (-V?T-PEEOU+*Z=-KWI>\_5Z_@K+Y!1117CGT@4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOA;J%VO\+7>NI;G\0L#_ ,ZPQ_P<0:AYO_)*;/R^X_X2%L_G]G_I0!^GE%?
M_P (_P#@OU\/_%>IPVOB[PGKWA%9F"FZMYUU.WA]WPL<F/\ =1C[5]P> ?B!
MHGQ2\(V.O>'=4LM9T;4H_,MKNUE$D<HZ'D=""""#R""" 010!L4444 %%%%
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M#V.(XS[35^<O_!,+X-?\+O\ VWO VG2P^;8Z5>?VU>9&5$=J/-4-[-(L:?\
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M5M \C_"_Q<J1J68_8CP!UKR'0M;NO#.MV>I6,SV]]I\Z7-O*OWHI$8,K#W!
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M&&Q_Z^(__0A7]*E?S>_"OP]-XN^)_AO2;=6>XU35+6TC4#EFDE5 /S-?TA4
M%%%% !1110!^67_!PO\ \E,^&O\ V#+S_P!&QUY%_P $2O\ D_C1?^P7?_\
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M8>Q'%25_.1\+OC?XP^">LIJ'A'Q-K7AVZ5@Q:QNWB63V=0=KCV8$'TK]+?\
M@GE_P6;7XIZ]8>"?BQ]BT_6KQE@T_7XE$-O>R'A8[A!\L;L> ZX0DX(7J>3,
M.%L1AX.I2?.EOI9_=K^9Z.3<>X/&5%1KQ]G)[7=XOYZ6^:MYGZ%4445\N?=A
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7F_[9/\ R:%\5O\ L3]7_P#2*:O2*IZ_H-EXJT&^TO4K6"^T[4K>2UNK
M:9 \=Q$ZE71@>"K*2"#U!H _FKK^A+]BG_DS?X3?]B;I'_I%#6=_PP!\$?\
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M&OWXK@_B;^RY\.?C1X@CU;Q9X)\->(M3B@6V2ZO[".:58E+,$W,,X!9CCW-
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M/_ :^>]*T?QI^T_\6C#:PZQXO\8>)+DR.1F:XN9#U=B>BCNQPJ@=@*_9P?\
M!(#]G5;L3?\ "NUW YV_VWJ)0G_=^T8_#I7LOPB_9\\#_ 33)+3P;X5T3PY%
M, )6LK58Y9\=/,D^^^/]HF@#@/\ @GO^R2O[&O[-VF^%[B2&XUV\E;4M9GBY
MC>ZD"@JIZE4140'OM+8&[%>X444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ74M8U.0*BJ/DA3^*61NB1J.2QZ#WP*F<XPBY2=DBZ=.=22A!7;T274^\O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;+$L\31R
M*KHX*LK#(8'J"*=10!\2?M6?\$0_ /QIU2ZUKP3?2?#_ %FY8R26T-N)]+F8
M\Y$.5,1)_N-M'9*^4/$/_!!SXT:5?M'97_@G5+?/RRQZC+'D>ZO$,'V&?J:_
M8JBO>PO$F.H1Y%+F7FK_ ([GR>.X*RK%3]HX<K>_*[?AM]R/RI^$7_!OUXOU
M34(I/''C30='L00SPZ1')>W#CNNZ18T0^_S@>AK]!?V7OV.O 7[(/A-M+\&:
M0+>:X ^V:C<MYU]?D=#))@<=PJA4!)PHR:]1HKEQV<XO%KEK2T[+1?\ !^9W
M97PUE^7RY\/#WN[U?X[?*P4445Y9[P4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
L0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
